Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Sep. 30, 2018 | Nov. 14, 2018 | |
Document And Entity Information | ||
Entity Registrant Name | QUANTUM MATERIALS CORP. | |
Entity Central Index Key | 1,403,570 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business Flag | true | |
Entity Emerging Growth Company | false | |
Entity Ex Transition Period | false | |
Entity Common Stock, Shares Outstanding | 458,396,956 | |
Trading Symbol | QTMM | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2,019 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
CURRENT ASSETS | ||
Cash and cash equivalents | $ 21,835 | $ 2,025 |
Subscription receivable | 10,000 | |
Prepaid expenses and other current assets | 1,208,978 | 1,746,181 |
TOTAL CURRENT ASSETS | 1,230,813 | 1,758,206 |
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $371,086 and $346,080 | 600,518 | 625,524 |
LICENSES AND PATENTS, net of accumulated amortization of $153,716 and $146,852 | 39,027 | 45,891 |
LONG TERM PORTION OF PREPAID EXPENSES | 147,886 | 184,660 |
TOTAL ASSETS | 2,018,244 | 2,614,281 |
CURRENT LIABILITIES | ||
Accounts payable | 1,586,314 | 1,511,691 |
Accrued expenses | 556,186 | 548,667 |
Accrued salaries | 853,018 | 682,575 |
Notes payable, net of unamortized discount | 20,000 | |
Short term derivative liability | 129,030 | |
Current portion of convertible debentures, net of unamortized discount | 3,472,214 | 3,402,421 |
TOTAL CURRENT LIABILITIES | 6,616,762 | 6,145,354 |
CONVERTIBLE DEBENTURES, net of current portion, unamortized discount and debt issuance costs | 85,239 | 40,224 |
TOTAL LIABILITIES | 6,702,001 | 6,185,578 |
COMMITMENTS AND CONTINGENCIES (See Note 10) | ||
STOCKHOLDERS' DEFICIT | ||
Common stock, $.001 par value, authorized 750,000,000shares, 450,969,648 and 442,564,332 issued and outstanding at September 30, 2018 and June 30, 2018, respectively | 450,970 | 442,564 |
Common stock issuable | 978,981 | 800,131 |
Additional paid-in capital | 42,355,411 | 42,030,181 |
Accumulated deficit | (48,469,119) | (46,844,173) |
TOTAL STOCKHOLDERS' DEFICIT | (4,683,757) | (3,571,297) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 2,018,244 | $ 2,614,281 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Statement of Financial Position [Abstract] | ||
Property and equipment, accumulated depreciation | $ 371,086 | $ 346,080 |
Licenses and patents, accumulated amortization | $ 153,716 | $ 146,852 |
Common stock, par value | $ .001 | $ .001 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, shares issued | 450,969,648 | 442,564,332 |
Common stock, shares outstanding | 450,969,648 | 442,564,332 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Income Statement [Abstract] | ||
REVENUES | $ 11,870 | |
OPERATING EXPENSES | ||
General and administrative | 1,361,732 | 1,267,453 |
Research and development | 23,087 | 77,942 |
TOTAL OPERATING EXPENSES | 1,384,819 | 1,345,395 |
LOSS FROM OPERATIONS | (1,384,819) | (1,333,525) |
OTHER EXPENSE (INCOME) | ||
Beneficial conversion expense | 16,870 | 752,426 |
Interest expense, net | 51,085 | 700,693 |
Change in value of derivative liability | 82,162 | (90,709) |
Accretion of debt discount | 90,010 | 331,162 |
TOTAL OTHER EXPENSE | 240,127 | 1,693,572 |
NET LOSS | $ (1,624,946) | $ (3,027,097) |
LOSS PER COMMON SHARE Basic and diluted | $ 0 | $ (0.01) |
WEIGHTED AVERAGE SHARES OUTSTANDING Basic and diluted | 471,961,937 | 375,593,837 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (1,624,946) | $ (3,027,097) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization expense | 31,870 | 34,487 |
Amortization of debt issuance costs, and debt discount | 460,457 | |
Stock-based compensation | 207,452 | 257,673 |
Stock issued for services | 670,370 | 504,648 |
Stock issued for interest | 18,608 | |
Beneficial conversion feature | 16,870 | 752,426 |
Deemed interest on extinguishment of debenture | 118,000 | |
Change in fair value of derivative liability | 82,162 | (90,709) |
Accretion of debt discount and warrant expense | 90,010 | 331,162 |
Effects of changes in operating assets and liabilities: | ||
Prepaid expenses and other current assets | (6,939) | 146,729 |
Accounts payable and accrued expenses | 335,182 | 148,488 |
Deferred revenue | ||
NET CASH USED IN OPERATING ACTIVITIES | (184,090) | (345,128) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from issuance of common stock | 83,900 | 40,000 |
Proceeds from issuance of convertible debentures / promissory note | 100,000 | 700,000 |
Proceeds from issuance of note payable | 20,000 | |
Principal payments on long-term debt | (237,300) | |
Principal payments on note payable | (50,056) | |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 203,900 | 452,644 |
NET DECREASE IN CASH | 19,810 | 107,516 |
CASH AND CASH EQUIVALENTS, beginning of period | 2,025 | 52,611 |
CASH AND CASH EQUIVALENTS, end of period | $ 21,835 | $ 160,127 |
Basis of Presentation
Basis of Presentation | 3 Months Ended |
Sep. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | NOTE 1 – BASIS OF PRESENTATION Nature of Operations Quantum Materials Corp., a Nevada corporation, and its wholly owned subsidiary, Solterra Renewable Technologies, Inc. (collectively referred to as the “Company”) are headquartered in San Marcos, Texas. The Company is a nanotechnology company specializing in the design, development, production and supply of quantum dots, including tetrapod quantum dots, a high-performance variant of quantum dots, and highly uniform nanoparticles, using its patented automated continuous flow production process. Quantum dots and other nanoparticles are expected to be increasingly utilized in a range of applications in the life sciences, television and display, solid state lighting, solar energy, battery, security ink, and sensor sectors of the market. Key uncertainties and risks to the Company include, but are not limited to, if and how quickly various industries adopt and fully embrace quantum dot technology and technological changes, including those developed by the Company’s competitors, rendering the Company’s technology uncompetitive or obsolete. Going Concern The Company recorded losses from continuing operations in the current period presented and has a history of losses. As of June 30, 2018, the Company had a working capital deficit of $5,385,949 and net cash used in operating activities was $(184,090) for the three months ended September 30, 2018. The ability of the Company to continue as a going concern is dependent upon its ability to reverse negative operating trends, obtain revenues from operations, raise additional capital, and/or obtain debt financing. In conjunction with anticipated revenue streams, management is currently negotiating equity and debt financing, the proceeds from which would be used to settle outstanding debts, to finance operations, and for general corporate purposes. However, there can be no assurance that the Company will be able to raise capital, obtain debt financing, or improve operating results sufficiently to continue as a going concern. The accompanying unaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern. Basis of Presentation: Use of Estimates: Financial Instruments: Property and Equipment: Furniture and fixtures 7 years Computers and software 3 years Machinery and equipment 3 - 10 years Licenses and Patents: Debt Issuance Costs: Earnings per Share: “Earnings Per Share” Beneficial Conversion: Derivative Instruments: Accounting for Derivative Instruments and Hedging Activities”, The Company estimates fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered consistent with the objective measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as freestanding warrants, the Company generally uses the Black-Scholes model, adjusted for the effect of dilution, because it embodies all the requisite assumptions (including trading volatility, estimated terms, dilution and risk-free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as Black-Scholes model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, income (expense) going forward will reflect the volatility in these estimates and assumption changes. Increases in the trading price of the Company’s common stock and increases in fair value during a given financial quarter result in the application of non-cash derivative expense. Conversely, decreases in the trading price of the Company’s common stock and decreases in trading fair value during a given financial quarter result in the application of non-cash derivative income. Fair value measurements: Recent Accounting Pronouncements In July 2017, the FASB issued ASU 2017-11—Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. ASU 2017-11 eliminates the requirement that a down round feature precludes equity classification when assessing whether an instrument is indexed to an entity’s own stock. A freestanding equity-linked financial instrument no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The Company elected to adopt ASU 2017-11 early, effective July 1, 2017, and implemented the pronouncement retrospectively with a cumulative effect adjustment to outstanding financial instruments. The adoption of this guidance did not have an impact on its financial statements. In the fiscal year 2018, the Company had three triggering events related to a down round feature which resulted in recording a charge for beneficial conversion expense of $1,021,500 during the year ended June 30, 2018. In March 2016, the FASB issued ASU guidance related to stock-based compensation. The new guidance simplifies the accounting for stock-based compensation transactions, including income tax consequences, statement of cash flows presentation, estimating forfeitures when calculating compensation expense, and classification of awards as either equity or liabilities. The new standard requires all excess tax benefits and tax deficiencies to be recognized as income tax benefit (expense) in the income statement. The new guidance also requires presentation of excess tax benefits as an operating activity on the statement of cash flows rather than a financing activity and requires presentation of cash paid to a tax authority when shares are withheld to satisfy the employer’s statutory income tax withholding obligation as a financing activity. The new guidance also provides for an election to account for forfeitures of stock-based compensation. The Company adopted the guidance effective July 1, 2017. With respect to the forfeiture election, the Company will continue its current practice of estimating forfeitures when calculating compensation expense. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements or related disclosures. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting. In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the “Tax Act”) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The Company adopted the guidance effective July 1, 2018. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements or related disclosures. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718) – Scope of Modification Accounting. Pronouncements Yet To Be Adopted In February 2016, the FASB issued ASU 2016-02, Leases, In August 2014, the FASB issued ASU No. 2014-15 Preparation of Financial Statements — Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers Revenue from Contracts with Customers: Deferral of the Effective Date, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing. |
Property and Equipment
Property and Equipment | 3 Months Ended |
Sep. 30, 2018 | |
Property, Plant and Equipment [Abstract] | |
Property and Equipment | NOTE 2 – PROPERTY AND EQUIPMENT Property and equipment consisted of the following: September 30, 2018 June 30, 2018 (unaudited) Furniture and fixtures $ 3,502 $ 3,502 Computers and software 11,447 11,447 Machinery and equipment 956,655 956,655 971,604 971,604 Less: accumulated depreciation 371,086 346,080 Total property and equipment, net $ 600,518 $ 625,524 Depreciation expense for the three months ended September 30, 2018 and 2017 was $25,006 and $24,850, respectively. |
Licenses and Patents
Licenses and Patents | 3 Months Ended |
Sep. 30, 2018 | |
Finite-Lived Intangible Assets, Net [Abstract] | |
Licenses and Patents | NOTE 3 – LICENSES AND PATENTS Licenses and patents consisted of the following: September 30, 2018 June 30, 2018 (unaudited) William Marsh Rice University $ 40,000 $ 40,000 University of Arizona 15,000 15,000 Bayer acquired patents 137,743 137,743 192,743 192,743 Less: accumulated amortization 153,716 146,852 Total licenses and patents, net $ 39,027 $ 45,891 Amortization expense for the three months ended September 30, 2018 and 2017 $6,864 and $9,637, respectively. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Sep. 30, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Fair Value of Financial Instruments | NOTE 4 – FAIR VALUE OF FINANCIAL INSTRUMENTS The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2011-04 “Fair Value Measurement” This guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Hierarchical levels, as defined in this guidance and directly related to the amount of subjectivity associated with the inputs to fair valuations of these assets and liabilities are as follows: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 – Valuations based on unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment. As of September 30, 2018, and June 30, 2018, the fair value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximates book value due to the short maturity of these instruments. Based upon borrowing rates currently available to the Company for loans with similar terms, the carrying value of its debt obligations approximates fair value. As of September 30, 2018, and June 30, 2018, the Company held no investments. The Company hired an independent resource to value its derivative liability as follows (unaudited): Fair Value Table Balance at September 30, 2018 Quoted Prices in Active Markets for Identical Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Derivative Liability $ 129,030 $ - $ - $ 129,030 Note Payable $ 20,000 - 20,000 - Convertible debentures 3,557,453 - 3,557,453 - $ 3,706,483 $ - $ 3,577,453 $ 129,030 Level Three Roll-forward Derivative Liability Total Balance June 30, 2018 $ - $ - Fair value of derivative liability reclassified from equity 98,645 98,645 Settlement of derivative liabilities (51,777 ) (51,777 ) Change in fair value 82,162 82,162 Balance September 30, 2018 $ 129,030 $ 129,030 Convertible Debentures The Company measured the estimated fair value of the convertible debentures using significant other observable inputs, representative of a Level 2 fair value measurement, including the interest and conversion rates for the instruments. The following table sets forth the fair value of the Company’s convertible debentures as of September 30, 2018, and June 30, 2018: September 30, 2018 June 30, 2018 (unaudited) Carrying Fair Carrying Fair Amount Value Amount Value Convertible debentures issued in September 2014 $ 25,050 $ 29,044 $ 25,050 $ 27,977 Convertible debentures issued in January 2015 500,000 523,567 500,000 504,342 Convertible debentures issued in April - June 2016 1,075,000 1,198,851 1,075,000 1,154,831 Convertible debenture issued in August 2016 200,000 235,613 200,000 226,961 Convertible debentures issued in January - March 2017 60,000 66,583 60,000 64,138 Convertible promissory notes issued in March 2017 222,350 268,550 222,350 258,689 Convertible debenture issued in June 2017 100,000 102,689 100,000 98,919 Convertible debenture issued in July 2017 100,000 102,689 100,000 98,919 Convertible debenture issued in September 2017 150,000 154,034 150,000 148,378 Convertible debenture issued in September 2017 495,000 509,554 495,000 490,844 Convertible debenture issued in November 2017 27,000 26,521 27,000 25,547 Convertible debenture issued in November 2017 247,500 254,777 247,500 245,422 Convertible debenture issued in December 2017 75,000 75,252 75,000 72,489 Convertible debenture issued in February 2018 45,000 46,079 45,000 44,387 Convertible debentures issued in March 2018 65,000 65,614 65,000 63,205 Convertible debentures issued in April 2018 150,000 136,456 150,000 131,446 Convertible debentures issued in June 2018 40,000 41,614 40,000 40,086 Convertible debentures issued in July 2018 45,000 46,229 - - Convertible debentures issued in August 2018 30,000 30,101 - - Convertible debentures issued in September 2018 25,000 24,770 - - Convertible promissory note issued in September 2018 20,000 19,865 - - The Company is not a party to any hedge arrangements or commodity swap agreement. |
Convertible Debentures
Convertible Debentures | 3 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Convertible Debentures | NOTE 5 – CONVERTIBLE DEBENTURES The following table sets forth activity associated with the convertible debentures: September 30, June 30, Debenture 2018 2018 Reference (unaudited) Convertible debentures issued in September 2014 $ 25,050 $ 25,050 A Convertible debentures issued in January 2015 500,000 500,000 B Convertible debentures issued in April - June 2016 1,075,000 1,075,000 C Convertible debenture issued in August 2016 200,000 200,000 C Convertible debentures issued in January - March 2017 60,000 60,000 D Convertible promissory notes issued in March 2017 222,350 222,350 G Convertible debenture issued in June 2017 100,000 100,000 I Convertible debenture issued in July 2017 100,000 100,000 J Convertible debenture issued in September 2017 645,000 645,000 K Convertible debenture issued in November 2017 247,500 247,500 K Convertible debenture issued in November 2017 27,000 27,000 L Convertible debenture issued in December 2017 75,000 75,000 N Convertible debenture issued in February 2018 45,000 45,000 O Convertible debentures issued in March 2018 65,000 65,000 P Convertible debentures issued in April 2018 60,000 60,000 Q Convertible debentures issued in April 2018 70,000 70,000 R Convertible debentures issued in April 2018 20,000 20,000 S Convertible debentures issued in June 2018 40,000 40,000 T Convertible debentures issued in July 2018 45,000 - U Convertible debentures issued in August 2018 30,000 - V Convertible debentures issued in September 2018 25,000 - W 3,676,900 3,576,900 Less: unamortized discount 119,447 134,255 3,557,453 3,442,645 Less: current portion 3,472,214 3,402,421 Total convertible debentures, net of current portion $ 85,239 $ 40,224 A) September 2014 Convertible Debenture Between September 16, 2014 and October 28, 2014, the Company entered into Convertible Debenture Agreements to obtain a total of $500,050 in gross proceeds from five non-affiliated parties (collectively hereinafter referred to as the “Debenture Holders”). The Debentures have terms of five years maturing between September 16, 2019 and October 30, 2019. The Debentures bear interest at the rate of 6% per annum and are pre-payable by the Company at any time without penalty. The Debenture Holders have the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.15 per share at any date and will receive an equal number of warrants having a strike price of $0.30 per share and a term of five years. None of the Debentures were converted into common shares during the year ended June 30, 2018. Interest expense for the three months ended September 30, 2018 and 2017 was $384 and $384, respectively As of September 30, and June 30, 2018, $25,050 of principal was outstanding. B) January 2015 Convertible Debenture On January 15, 2015, the Company entered into Convertible Debenture Agreements to obtain $500,000 in gross proceeds from two non-affiliated parties (collectively hereinafter referred to as the “Debenture Holders”). The Debentures have a term of two years maturing on January 15, 2017 and bear interest at the rate of 8% per annum. The debentures are pre-payable by the Company at any time without penalty. The Debenture Holders have the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.06 per share at any date. The Debenture Holders received 6,250,000 common stock warrants exercisable at $0.06 per share through January 15, 2017. The debt is secured by a security interest in certain microreactor equipment. The Agreement also provides for the investors to have the right to appoint one member to the Company’s Board of Directors in the event any one of the aforementioned debentures are converted into common stock of the Company. On October 10, 2016, the maturity date of the debentures was extended to January 15, 2018 and the 6,250,000 warrants were converted into common stock for total proceeds of $375,000. On January 12, 2018 the debentures were extended for ten days to January 25, 2018. On January 24, 2018, the debentures were extended to December 15, 2018. As compensation for extending the debentures, the Debenture Holders received 3,500,000 shares of Common Stock, which were valued at $0.06 per share, a total of $210,000 recorded as debt extension expense. In accounting for the convertible debentures, the Company allocated the fair value of the warrants to the proceeds received in the amount of $348,105, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, two years. Interest expense for the three months ended September 30, 2018 and 2017 was $10,082 and $10,082, respectively. As of September 30, and June 30, 2018, $500,000 of principal was outstanding. C) April – June, August, October and November 2016 Convertible Debentures During the fourth quarter of the year ended June 30, 2017, the Company sold 1,565 Units for total proceeds of $1,565,000 from three affiliated and fourteen non-affiliated parties. In August 2016 the Company sold 200 additional Units for total proceeds of $200,000 and sold $50,000 in proceeds in October 2016. Each Unit consists of a $1,000 Unsecured Convertible Promissory Note (each, a “Note”) and a warrant to purchase 4,166 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.15 per share (each, a “Warrant”) over a period of five years. The Notes which were issued at face value have a maturity of two years from the date of issuance, bear interest at the rate of 8% per annum and are convertible into unregistered and restricted shares of Common Stock at $0.12 per-share, subject to normal and customary adjustments including (a) any subdivisions, combinations and classifications of the Common Stock; or (b) any payment, issuance or distribution by the Company to its stockholders of (i) a stock dividend, (ii) debt securities of the Company, or (iii) assets (other than cash dividends payable out of earnings or surplus in the ordinary course of business). The conversion price also is subject to a full ratchet adjustment upon the Company’s issuance of Common Stock, warrants, or rights to purchase Common Stock or securities convertible into Common Stock for a consideration per share which is less than the then applicable conversion price of the Notes excluding Common Stock and options issued to officers, directors, and employees of the Company, except for the exercise or conversion of existing convertible securities of the Company. The conversion price was reset to $0.012 per share in June 2018 as a result of a triggering event. In accounting for the convertible debentures, the Company allocated the fair value of the warrants to the proceeds received in the amount of $609,595, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, two years. The Company recognized accretion of debt discount expense for the years ended June 30, 2018, and 2017, of $2,564 and $96,331, respectively. The Company recognized a beneficial conversion expense for the three months ended September 30, 2018, and 2017, of $0 and $530,000, respectively. Interest expense for the three months ended September 30, 2018, and 2017, of $26,067 and $31,444, respectively. During the years ended June 30, 2018 and 2017, $455,000 and $285,000 of principal was converted into 3,791,666 and 2,375,000 shares of common stock respectively. As of September 30, and June 30, 2018, $1,275,000 of principal was outstanding. As of the date of this report, maturities totaling $825,000 of principal have been extended for one year until March and April of 2019, and the remaining $250,000 have not been extended, and are past due as of the date of this report. D) January-March 2017 Convertible Debentures During the third quarter of the year ended June 30, 2017, the Company sold 2,600 Units for total proceeds of $260,000 from five non-affiliated parties. Each Unit consists of a $1,000 Unsecured Convertible Promissory Note (each, a “Note”) and a warrant to purchase 4,166 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.15 per share (each, a “Warrant”) over a period of five years. The Notes which were issued at face value have a maturity of two years from the date of issuance, bear interest at the rate of 8% per annum and are convertible into unregistered and restricted shares of Common Stock at $0.12 per-share, subject to normal and customary adjustments including (a) any subdivisions, combinations and classifications of the Common Stock; or (b) any payment, issuance or distribution by the Company to its stockholders of (i) a stock dividend, (ii) debt securities of the Company, or (iii) assets (other than cash dividends payable out of earnings or surplus in the ordinary course of business). The conversion price also is subject to a full ratchet adjustment upon the Company’s issuance of Common Stock, warrants, or rights to purchase Common Stock or securities convertible into Common Stock for a consideration per share which is less than the then applicable conversion price of the Notes excluding Common Stock and options issued to officers, directors, and employees of the Company, except for the exercise or conversion of existing convertible securities of the Company. In evaluating the accounting treatment of this anti-dilution feature, the Company believes that is has control over whether the anti-dilution feature will be exercised. The Company is able to decide on which type of financing is raised, and thus the Company can prevent the issuance of shares at a price below the anti-dilution strike price. The number of Warrants and exercise price is proportionately adjustable for events including subdivisions, combinations or consolidations, reclassifications, exchanges, mergers, and reorganizations. In accounting for the convertible debentures, the Company allocated the fair value of the warrants to the proceeds received in the amount of $73,250, recorded as debt discount and is amortized using the effective interest rate method over the life of the loans, two years. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $1,547 and $8,864, respectively. During the year ended June 30, 2018, $200,000 of these debentures converted into 1,666,667 shares of common stock. Interest expense for the three months ended September 30, 2018 and 2017 of $1,210 and $5,243, respectively. As of September 30, and June 30, 2018, $60,000 of principal was outstanding. G) March 2017 Convertible Promissory Notes In March 2017, the Company entered into Convertible Promissory Notes with SBI Investment LLC, 2014-1 (“SBI”) and L2 Capital, LLC (“L2 Capital”) to obtain $285,000 in gross proceeds. In connection with the first funding tranche, SBI and L2 received 253,525 and 760,576 common stock warrants, respectively, exercisable at $0.13 per share through March 28, 2022. At each subsequent funding to the first tranche, the Company will issue to each of SBI and L2 Capital warrants to purchase 50% of the total amount of each tranche funded plus the applicable original issue discount, divided by the lesser of (i) the closing bid of the common stock on March 29, 2017 and (ii) the closing bid price of the common stock on the funding date of each respective tranche. The promissory notes have a term of six months from the issuance date and bear interest at the rate of 6% per annum. The promissory notes are not pre-payable by the Company without penalty. The promissory notes are convertible into unregistered and restricted shares of Common Stock only if there is an Event of Default as defined in the notes. In March 2017, the Company entered into an equity purchase agreement (“Eloc”) with SBI and L2 Capital, allowing them to purchase up to $5,000,000 of the Company’s common stock. As consideration for SBI and L2 Capital, the Company agreed to pay SBI and L2 Capital commitment fees of $63,000 and $147,000, respectively. These commitment fees were issued in the form of promissory notes, which bear interest at 8% per annum and have mature nine months from the date of issuance. The promissory notes are convertible into unregistered and restricted shares of Common Stock only if there is an Event of Default as defined in the notes. In accounting for the convertible promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $86,673, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, eight months. The Company also recorded original issue discount (“OID”) of $31,850 as debt discount and is amortized using the effective interest rate method over the life of the loan, eight months. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $0 and $43,661, respectively. Interest expense for the three months ended September 30, 2018 and 2017 of $0 and $8,364, respectively. As of September 30, 2017, the Company had a derivative liability of $307,301, unamortized discount of $69,333, and recognized interest expense of $340,476, and a change in derivative liability benefit of $65,703. As of September 30, 2018, the Company no longer had a derivative liability, and recognized a change in derivative liability benefit of $0 for the three months ended September 30, 2018. As of September 30, and June 30, 2018, and 2017, $222,350 of principal was outstanding, respectively. During the year ended June 30, 2018, the Company paid $319,500 of principal. I) June 2017 Convertible Debenture In June 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $100,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $100,000. The Note Holder received 250,000 common stock warrants exercisable at $0.12 per share through June 15, 2020. The promissory note has a term of six months maturing on December 16, 2017 and stipulates a one-time interest charge of eight percent (8%) shall be applied on the issuance date to the principal. The maturity date of the Note was extended to May 1, 2018 in an extension agreement dated April 6, 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $54,340, recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. Interest expense was recorded for the three months ended September 30, 2018 and 2017 of $0. Beneficial conversion expense was recorded for the three months ended September 30, 2018 and 2017 of $0. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $0 and $27,079, respectively. As of September 30, and June 30, 2018, and 2017, $100,000 of principal was outstanding. In May 2018 the maturity date was extended to February 1, 2019. J) July 2017 Convertible Debenture In July 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $100,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $100,000. The Note Holder received 1,000,000 shares of common stock and 250,000 common stock warrants exercisable at $0.12 per share through September 11, 2000. The promissory note has a term of six months maturing on December 16, 2017 and stipulates a interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to May24, 2018 in an extension agreement dated April 6, 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $19,010 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. The Company recognized a fair value of the common shares issued at $100,000. The Company recorded a debenture discount of $53,876 and a beneficial conversion expense of $45,544. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $0 and $21,300, respectively. As of September 30, and June 30, 2017, $100,000 of principal was outstanding. In May 2018 the maturity date was extended to February 1, 2019. As part of the extension agreement, a derivative liability was created, in connection to a “make-whole” provision. The value of this derivative at September 30, 2018 was $49,798, and a change in derivative liability expense of $28,561 for the three months then ended. Interest expense for the three months ended September 30, 2018 and 2017 of $0 and $8,000, respectively. K) September 2017 Convertible Debenture Debenture A) In September 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $150,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $150,000. The Note Holder received 1,650,000 shares of common stock and 375,000 common stock warrants exercisable at $0.12 per share through September 11, 2000. The promissory note has a term of six months maturing on March 26, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to February 1, 2019 in an extension agreement dated May 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $19,420 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. The Company recognized a fair value of the common shares issued at $165,000. The Company recorded a debenture discount of $82,720 and a beneficial conversion expense of $45,219. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $0 and $8,587, respectively. As of September 30, and June 30, 2018, $150,000 of principal was outstanding. In May 2018 the maturity date was extended to February 1, 2019. As part of the extension agreement, a derivative liability was created, in connection to a “make-whole” provision. The value of this derivative at September 30, 2018 was $22,666, and a change in derivative liability expense of $14,483 for the three months then ended. Interest expense for the three months ended June 30, 2018 and 2017 of $0 and $12,000, respectively. Debenture B) In September 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $450,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $495,000. The Note Holder received 10,000,000 shares of common stock and 2,000,000 common stock warrants exercisable at $0.12 per share through September 11, 2000. The promissory note has a term of seven months maturing on April 26, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to January 26, 2019 in an extension agreement dated April 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $318,337 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, seven months. The Company also recorded original issue discount (“OID”) of $45,000 as debt discount and is amortized using the effective interest rate method over the life of the loan, eight months. The Company recognized a fair value of the common shares issued at $1,000,000. The Company recorded a debenture discount of $318,337 and a beneficial conversion expense of $131,663. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $0 and $7,429, respectively. As of September 30, and June 30, 2018, $495,000 of principal was outstanding. In May 2018 the maturity date was extended to February 1, 2019. As part of the extension agreement, a derivative liability was created, in connection to a “make-whole” provision. The value of this derivative at September 30, 2018 was $43,998, and a change in derivative liability expense of $28,864 for the three months then ended. Interest expense for the three months ended September 30, 2018 and 2017 of $0 and $36,000, respectively. Debenture C) In November 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $225,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $247,500. The promissory note has a term of six months maturing on April 26, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to January 26, 2019 in an extension agreement dated April 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. The Company also recorded original issue discount (“OID”) of $22,500 as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. As of September 30, and June 30, 2018, $247,500 of principal was outstanding. Interest expense for the three months ended September 30, 2018 and 2017 of $0 and $18,000, respectively. L) November 2017 Convertible Debenture In November 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $27,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $27,000. The Note Holder received 416,600 common stock warrants exercisable at $0.15 per share through November 7, 2022. The promissory note has a term of 24 months maturing on November 13, 2019 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the Company allocated the fair value of the warrants to the proceeds received in the amount of $8,310 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, 24 months. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $780 and $0, respectively. Interest expense for the three months ended September 30, 2018 and 2017 of $552 and $0, respectively. As of September 30, and June 30, 2018, $27,000 of principal was outstanding. N) December 2017 Convertible Debenture In December 2017, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $75,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $75,000. The Note Holder received 1,000,000 shares of common stock and 250,000 common stock warrants exercisable at $0.12 per share through December 27, 2020. The promissory note has a term of 6 months maturing on June 30, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to March 30, 2019 in an extension agreement dated June 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the company recorded a beneficial conversion expense of $16,176 and the Company allocated the fair value of the warrants to the proceeds received in the amount of $41,175 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $0. Interest expense for the three months ended September 30, 2018 and 2017 of $0. As of September 30, and June 30, 2018, $75,000 of principal was outstanding. The debenture agreement includes a “make-whole” provision, creating a potential derivative liability. The value of this derivative at September 30, 2018 was $10,380, and a change in derivative liability expense of $8,061 for the three months then ended. O) February 2018 Convertible Debenture In February 2018, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $45,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $45,000. The Note Holder received 1,500,000 shares of common stock and 500,000 common stock warrants exercisable at $0.12 per share through December 27, 2020. The promissory note has a term of 6 months maturing on August 8, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to February 8, 2019 in an extension agreement dated August 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the company recorded a beneficial conversion expense of $9,046 and the Company allocated the fair value of the warrants to the proceeds received in the amount of $31,546 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $6,761 and $0, respectively. Interest expense for the three months ended September 30, 2018 and 2017 of $0. As of September 30, and June 30, 2018, $45,000 of principal was outstanding. The debenture agreement includes a “make-whole” provision, creating a potential derivative liability. The value of this derivative at September 30, 2018 was $64, and a change in derivative liability expense of $64 for the three months then ended. P) March 2018 Convertible Debenture In March 2018, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $30,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $30,000. The Note Holder received 1,500,000 shares of common stock and 500,000 common stock warrants exercisable at $0.12 per share through March 6, 2021. The promissory note has a term of 6 months maturing on August 8, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to March 6, 2019 in an extension agreement dated August 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of Common Stock at a conversion price of $0.12 per share at any date. The promissory note includes piggyback registration rights and the Company shall include on the next registration statement it files with the SEC all shares issuable upon conversion of the note. In accounting for the convertible promissory note, the company recorded a beneficial conversion expense of $6,625 and the Company allocated the fair value of the warrants to the proceeds received in the amount of $23,374 recorded as debt discount and is amortized using the effective interest rate method over the life of the loan, six months. The Company recognized accretion of debt discount expense for the three months ended September 30, 2018 and 2017 of $8,677 and $0, respectively. Interest expense for the three months ended September 30, 2018 and 2017 of $0 was recognized. As of September 30, and June 30, 2018, $30,000 of principal was outstanding. In March 2018, the Company entered into a Securities Purchase Agreement and Convertible Promissory Note to obtain $35,000 in gross proceeds from a non-affiliated party (collectively hereinafter referred to as the “Note Holder”) in exchange for a convertible promissory note in the principal amount of $35,000. The Note Holder received 1,500,000 shares of common stock and 500,000 common stock warrants exercisable at $0.12 per share through March 23, 2021. The promissory note has a term of six months maturing on September 23, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to March 23, 2019 in an extension agreement dated September 2018. The promissory note is pre-payable by the Company at any time without penalty. The Note Holder has the right of conversion into unregistered and restricted shares of |
Notes Payable
Notes Payable | 3 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Notes Payable | NOTE 6 – NOTES PAYABLE Promissory Note In September 2018, the Company issued a promissory note secured by the Company’s CEO for $20,000 with interest rate of 6%, maturing on March 9, 2019. The note is convertible into the Company’s common stock, at the lenders discretion, at a rate of $.04 per share, with warrants to purchase an equal amount of stock. Interest expense for the three months ended September 30, 2018 was $69. As of September 30, 2018, $20,000 of principal was outstanding. |
Equity Transactions
Equity Transactions | 3 Months Ended |
Sep. 30, 2018 | |
Equity [Abstract] | |
Equity Transactions | NOTE 7 – EQUITY TRANSACTIONS Common Stock During the three months ended September 30, 2018, the Company issued 3,031,375 shares for $121,255 in consulting services, $61,255 of which was accrued at June 30, 2018. During the three months ended September 30, 2018, the Company issued 344,055 shares of common stock at the fair market value of $21,997 for payment of debenture interest. During the three months ended September 30, 2018, the Company issued 4,516,553 shares of common stock at the fair market value of $180,663 in connection with debenture derivative liabilities, relieving $51,777 of the derivative liability. During the three months ended September 30, 2018, the Company issued 513,333 shares of common stock valued at $30,800, in shares that were recorded as common stock issuable at June 30, 2018. Common Stock Issuable As of September 30, 2018, the company owed a total of 31,313,779 shares of common stock. 3,500,000 shares were in exchange for extinguishment of a $150,000 debenture, with a fair value of $280,000. 991,279 shares were for the settlement of a derivative liability related to price protection in the extinguishment agreement, with a fair value of $39,651. 600,000 shares were in relation to the extension of debt, with a fair value of $36,000. 23,750,000 shares were in relation to a new debenture borrowing of $835,000 in aggregate, valued at $506,096. 1,430,833 shares were in relation to the sale of shares for cash, valued at $73,900. 1,041,667 shares were in exchange for services, with a fair value of $43,333. These subscribed shares also included 702,250 warrants to purchase shares of common stock at $0.04 per share. The shares are included in the weighted average shares outstanding for purposes of calculation earning per share for the three and three months ended September 30, 2018. 513,333 shares with a fair value of $30,800, were issued, reducing shares issuable, during the three months ended September 30, 2018. Stock Warrants A summary of activity of the Company’s stock warrants for the three months ended September 30, 2018 is presented below (unaudited): Weighted Weighted Average Weighted Average Remaining Average Exercise Number of Contractual Grant Date Price Warrants Term in Years Fair Value Balance as of June 30, 2018 $ 0.11 36,781,726 2.80 $ 0.09 Expired - - - Granted 0.10 3,702,250 0.04 Exercised - - - Cancelled - - - - Balance as of September 30, 2018 $ 0.11 40,483,976 2.49 $ 0.09 Vested and exercisable as of September 30, 2018 $ 0.11 40,483,976 2.49 $ 0.09 Outstanding warrants at September 30, 2018 expire during the period February 2019 to April 2023 and have exercise prices ranging from $0.03 to $0.30, valued at $4,538,009. These warrants are issued for salary conversions of employees and consultants, and the origination warrants related to debentures. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Sep. 30, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Compensation | NOTE 8 – STOCK-BASED COMPENSATION The Company follows FASB Accounting Standards Codification (“ASC”) 718 “Compensation — Stock Compensation” In October 2009 the Board of Directors authorized the approval of a stock option plan covering 7,500,000 shares of common stock, which was increased to 10,000,000 shares in December 2009 and approved by stockholders in January 2010. The Plan provides for the direct issuance of common stock and the grant of incentive and non-incentive stock options. As of September 30, 2018, 9,200,000 options have been granted, with terms ranging from five to ten years, and 800,000 have been cancelled leaving a balance of 8,400,000 of options outstanding. During the three months ended September 30, 2018, we issued 1,500,000 shares of restricted stock out of the plan, leaving 100,000 options or grants available for grant under the plan. In March 2012, 3,500,000 stock options, with a term of five years, were granted outside of a stock option plan. In March 2017, the term of these options was extended for an additional five years. In June 2016, and 2017, 6,000,000 and 17,000,000 stock options, with a term of ten years, were granted, respectively, outside of a stock option plan, and 3,000,000 shares were cancelled, leaving a balance of 23,500,000 outstanding outside of a defined option plan. In January 2013 the Board of Directors authorized the approval of a stock option plan covering 20,000,000 shares of common stock, which was increased to 60,000,000 shares in March 2013 and approved by stockholders in March 2013. The Plan provides for the direct issuance of common stock and the grant of incentive and non-incentive stock options. As of September 30, 2018, 72,653,473 options have been granted, with terms ranging from five to ten years, 3,325,000 have been exercised and 18,886,559 have been cancelled, and 50,441,914 remain outstanding. On February 17, 2016, the Shareholders approved the 2015 Employee Benefit and Consulting Services Compensation Plan covering 15,000,000 shares. The Plan provides for the direct issuance of common stock and the grant of incentive and non-incentive stock options. As of September 30, 2018, 4,900,000 options have been granted with a term of five years, and 1,625,000 have been cancelled leaving a balance outstanding of 3,275,000 options. Incentive Stock Options: The following assumptions were used for the periods indicated: Three Months Ended September 30, 2018 2017 (unaudited) Expected volatility - 136.25 % Expected dividend yield - - Risk-free interest rates - 1.62 % Expected term (in years) - 5.0 The computation of expected volatility during the three months ended September 30, 2017 was based on the historical volatility. Historical volatility was calculated from historical data for the time approximately equal to the expected term of the option award starting from the grant date. The risk-free interest rate assumption is based upon the U.S. Treasury yield curve in effect at the time of grant for the period corresponding with the expected life of the option. As no options were granted during the three months ended September 30, 2018, no corresponding assumptions were calculated. A summary of the activity of the Company’s stock options for the three months ended September 30, 2018 is presented below (unaudited): Weighted Weighted Weighted Average Average Average Number of Remaining Optioned Aggregate Exercise Optioned Contractual Grant Date Intrinsic Price Shares Term in Years Fair Value Value Balance as of June 30, 2018 $ 0.09 85,616,914 4.00 $ 0.11 $ - Expired - - - Granted - - - Exercised - - - Cancelled - - - Balance as of September 30, 2018 $ 0.09 85,616,914 3.75 $ 0.11 $ - Vested and exercisable as of September 30, 2018 $ 0.08 78,634,747 3.77 $ 0.11 $ - Outstanding options at September 30, 2018, expire during the period February 2019 to June 2026 and have exercise prices ranging from $0.05 to $0.17. Compensation expense associated with stock options for the three months ended September 30, 2018 and 2017 was $207,452 and $207,451 respectively and was included in general and administrative expenses in the consolidated statements of operations. At September 30, 2018, the Company had 6,982,167 shares of nonvested stock option awards. The total cost of nonvested stock option awards which the Company had not yet recognized was $487,582 at September 30, 2018. Such amounts are expected to be recognized over a period of 1.0 years. Restricted Stock: Number of Nonvested, Unissued Restricted Share Awards Weighted Average Grant Date Fair Value Nonvested, unissued restricted shares outstanding at June 30, 2017 1,500,000 0.21 Granted 5,500,000 0.06 Vested (7,000,000 ) 0.09 Forfeited - - Nonvested, unissued restricted shares outstanding at June 30, 2018 - $ - Granted - - Vested - - Forfeited - - Nonvested, unissued restricted shares outstanding at September 30, 2018 - $ - Compensation expense associated with restricted stock awards for the three months ended September 30, 2018 and 2017 was $0 and $50,222, respectively, and was included in general and administrative expenses in the consolidated statements of operations. The total cost of nonvested stock awards which the Company had not yet recognized was $0 at September 30, 2018. |
Loss Per Share
Loss Per Share | 3 Months Ended |
Sep. 30, 2018 | |
Earnings Per Share [Abstract] | |
Loss Per Share | NOTE 9 – LOSS PER SHARE The Company follows ASC 260, “Earnings Per Share”, The following table sets forth the computation of basic and diluted loss per share: Three Months Ended September 30, 2018 2017 (unaudited) Net loss $ (1,624,946 ) $ (3,027,097 ) Weighted average common shares outstanding: Basic and diluted 471,961,937 375,593,837 Basic and diluted loss per share $ (0.00 ) $ (0.01 ) |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Sep. 30, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 10 - COMMITMENTS AND CONTINGENCIES Agreement with University of Arizona Solterra entered into an exclusive Patent License Agreement with the University of Arizona (“UA”) in July 2009. On March 3, 2017, Solterra entered into an amended license agreement with UA. Pursuant to UA License Agreement, as amended, Solterra is obligated to pay minimum annual royalties of $50,000 by June 30, 2017, $125,000 by September 15, 2017 and $200,000 on each June 30th thereafter, subject to adjustments for increases in the consumer price index. Such minimum royalty payments shall be credited against royalties due in each respective royalty year, July 1 to June 30, following the due date. Royalties based on net sales are 2% of net sales of licensed products for non-display electronic component applications and 2.5% of net sales of licensed products for printed electronic displays. The UA License Agreements and subsequent amendments have been filed on Form 8-K and are incorporated by reference herein. The Company is in the process of renegotiating the minimum royalty commitments and while oral modifications have been agreed to a final amendment has not been finalized. As of September 30, 2017, no royalties have been accrued for this obligation. Agreement with Texas State University The Company entered into a Service Agreement with Texas State University (“TSU”) by which the Company occupies certain office and lab space at TSU’s STAR Park (Science Technology and Advanced Research) Facility. The agreement is month-to-month and can be terminated with 60-days written notice of either party. Operating Leases The Company leases certain office and lab space under a month-to-month operating lease agreement. Rental expense for the operating lease for the three months ended September 30, 2018 and 2017 was $18,864 and $29,952, respectively. |
Litigation
Litigation | 3 Months Ended |
Sep. 30, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
Litigation | NOTE 11 — LITIGATION The Company was served in Hays County, Texas in a complaint for breach of contract in February 2017. In April 2017, the Company settled this complaint for $129,000 payable over a four-month period. As of the filing date of this Form 10-Q, the balance in arrears is $95,000 plus interest and other charges which has been accrued at September 30, 2018. The Company repaid $237,300 in principal plus interest to L2 Capital LLC and $101,700 plus interest to SBI Investments LLC on September 30, 2017, and $149,555 plus interest to L2 Capital LLC and $64,095 plus interest to SBI Investments LLC on November 3, 2017, respectively. CAUSE NUMBER 17-2033; Hays County, Texas Two lenders, SBI Investments LLC, 2014-1, and L2 Capital, LLC, asked Quantum Materials’ transfer agent, Empire Stock Transfer, Inc., to set aside fifty-million (50,000,000) shares of stock as collateral for four loan agreements Quantum Materials had entered into in late March 2017. This joint request occurred despite the fact that or about September 30, 2017 Quantum had repaid $339,000 (plus accrued interest of $10,170) on two of the loans. Subsequently, in November 2017, the Company also repaid $213,650 and $8,636 of accrued interest on two of the remaining loans on their due dates. Quantum filed suit for an injunction to stop the release of the stock. The two lenders, SBI Investments LLC, 2014-1 (SBI), and L2 Capital, LLC (L2), hired the national law firm of K&L Gates to stop the injunction; problematically, this same firm had previously represented Quantum Materials. Quantum filed a motion to disqualify the law firm for that conflict, and they subsequently withdrew. New counsel for SBI and L2, Cleveland Terrazas PLLC, brought suit against Quantum for $1.5 million on the four notes that had been repaid and were not in actual default, though SBI Investments LLC, 2014-1, and L2 Capital, LLC claimed technical defaults. The court in Hays County granted Quantum’s temporary injunction and set the full case for trial. The next day, SBI Investments LLC, 2014-1, and L2 Capital, LLC dismissed their suit against Quantum and refiled similar actions in Kansas and Florida on the notes claiming that one note was paid on a Monday when it was due on a Sunday, demanding late payment in stock (they refused cash), and another was paid on a Friday when it was due Saturday, claiming a pre-payment penalty. All three suits are related to the same transactions. The lenders claim 140% interest, attorney’s fees, 20 million shares of stock, and damages. Quantum maintains all loans have been paid timely. The Company denies all the above-mentioned allegations and will vigorously defend all claims. CAUSE NUMBER: 17CV06093; Johnson County, Kansas The Kansas lawsuit is based on the same nucleus of facts. The putative default is the failure to properly and timely file a Form S-1 with the SEC. Three causes of action are alleged: the first is breach of contracts regarding the Registration Rights Agreement against Quantum; the second claim is for breach of contract of the first L2 promissory note against Quantum; the final claim is for breach of contract regarding the second L2 promissory note against both Quantum and Squires, individually. The Company denies all the above-mentioned allegations and will vigorously defend all claims. CAUSE NUMBER: 2017-025283-CA-01; Miami-Dade County, Florida The Florida lawsuit largely mirrors the suit in Kansas; defaults are alleged as follows: On July 6, 2017, Quantum filed a revised Form 10-Q/A report (the Report) with the SEC, restating its financial statements. In comparison to the unrestated financial statement previously filed by Quantum, the Revised Report materially and adversely affects SBI’s rights with respect to the notes. This restatement of financial statements constituted a breach of each of the notes. Furthermore, because each note contains a cross-default clause, each of Quantum’s breaches of a specific note also constituted a breach of every other note. On July 27, 2017, Quantum’s auditor resigned, and replaced its auditor without seeking or obtaining the consent of SBI. This replacement of Quantum’s auditor constituted an alleged breach of the SBI notes. Because each note contains a cross-default clause, each of Quantum’s breaches of a specific note also constituted a breach of every other note. The Company denies all of the above-mentioned allegations and will vigorously defend all claims. The case was reheard in late March 2018 and a 45-day continuance was decided resulting in an April 30, 2018 rehearing. After a day of litigation in San Marcos, QTMM’s motion to enjoin L2 and SBI and prevent them from obtaining stock before a full trial on the merits was granted on October 27, 2017, by Judge Gary Steel. L2 and SBI objected to the injunction and appealed to the Third Court of Appeals in Austin, TX. On March 8, 2018, in a unanimous opinion, the Third Court of Appeals denied the appeal, sustained the injunction in favor of QTMM and awarded costs of court. On March 29, 2018, at a discovery hearing, wherein QTMM asked the court to order L2 and SBI to produce evidence to support their positions, L2 and SBI requested and received a stay of litigation, postponing the trial date of April 2018, which they had previously requested, and also postponing discovery until rulings in Florida and Kansas, or until further order of the court. The court also announced that when Florida and Kansas have spoken, discovery will be expedited. A jurisdiction hearing for the Florida case on August 15, 2018 resulted in the lawsuit being dismissed and a hearing is scheduled in Kansas in April 2019. The Company expects to successful in the L2 and SBI litigation. The ultimate outcome is not determinable and as such, no liability has been recorded for this contingent liability at March 31, 2018. Quantum v. K&L Gates, Inc., 18-2393, pending in Hays County, Texas. In September 2017, Quantum filed an injunction suit against two of its lenders, SBI Investments, LLC, 2014-1 and L2 Capital LLC, in Hays County, Texas (428th Judicial District; Cause No. 17-2033). On October 2017, these two lenders intervened in the proceeding, asserted affirmative claims for monetary damages against Quantum, and opposed Quantum’s request for temporary injunctive relief. The lenders’ law firm was K&L Gates. In 2016, the Board of Directors for Quantum retained the law firm of K&L Gates. In this professional capacity, K&L Gates attended confidential board meetings and reviewed, inter alia, corporate secrets. K&L Gates billed approximately $100,000 per month. The Company has accrued $319,000 in relation to this action. Quantum moved to disqualify K&L Gates. The day before Quantum’s motion to disqualify was ruled on, K&L Gates withdrew in lieu of the Austin law firm Cleveland & Terrazas. On September 21, 2018, the “Deputy General Counsel of K&L Gates,” Mr. Charles Tea, sent a demand for payment of over $300,000 to Quantum’s CEO. On October 16, 2018, Quantum filed suit against K&L Gates alleging Breach of Fiduciary Duty, Deceptive Trade Practices, and Legal Malpractice. |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 3 Months Ended |
Sep. 30, 2018 | |
Supplemental Cash Flow Elements [Abstract] | |
Supplemental Cash Flow Information | NOTE 12 – SUPPLEMENTAL CASH FLOW INFORMATION The following is supplemental cash flow information: Three Months Ended September 30, 2018 2017 (unaudited) Cash paid for interest $ - $ 13,544 Cash paid for income taxes $ - $ - The following is supplemental disclosure of non-cash investing and financing activities: Three Months Ended September 30, 2018 2017 (unaudited) Conversion of debentures, and accrued interest into shares of common stock $ 21,342 $ 318,608 Allocated value of common stock and warrants issued with convertible debentures $ 75,202 $ 454,933 Stock issued for amount in accounts payable $ 61,255 $ - Prepaid expense paid in shares of common stock $ 164,588 $ 184,307 Financing of prepaid insurance $ - $ 10,056 |
Transactions with Affiliated Pa
Transactions with Affiliated Parties | 3 Months Ended |
Sep. 30, 2018 | |
Related Party Transactions [Abstract] | |
Transactions with Affiliated Parties | NOTE 13 – TRANSACTIONS WITH AFFILIATED PARTIES At September 30, 2018 and 2017, the Company had accrued salaries payable to executives in the amount of $593,075 and $284,275, respectively. During the year ended June 30, 2017, the Company issued a convertible debenture to a family member of a former key executive for proceeds of $200,000. This transaction is described in more detail in Note 5 under the debenture reference C) April – June, August, October and November 2016 Convertible Debentures. In September 2016, the Company’s former Chief Financial Officer loaned the Company $100,000 to provide short-term bridge financing. The Company repaid the loan on October 11, 2016. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Sep. 30, 2018 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 14 - SUBSEQUENT EVENTS Quantum v. K&L Gates, Inc., 18-2393, pending in Hays County, Texas. In September 2017, Quantum filed an injunction suit against two of its lenders, SBI Investments, LLC, 2014-1 and L2 Capital LLC, in Hays County, Texas (428th Judicial District; Cause No. 17-2033). On October 2017, these two lenders intervened in the proceeding, asserted affirmative claims for monetary damages against Quantum, and opposed Quantum’s request for temporary injunctive relief. The lenders’ law firm was K&L Gates. Quantum moved to disqualify K&L Gates. In this professional capacity, K&L Gates attended confidential board meetings and reviewed, inter alia, corporate secrets. K&L Gates billed approximately $100,000 per month. The Company has accrued legal expenses of $319,000 in relation to this action. The day before Quantum’s motion to disqualify was ruled on, K&L Gates withdrew in lieu of the Austin law firm Cleveland & Terrazas. On September 21, 2018, the “Deputy General Counsel of K&L Gates,” Mr. Charles Tea, sent a demand for payment of over $300,000 to Quantum’s CEO. On October 16, 2018, Quantum filed suit against K&L Gates alleging Breach of Fiduciary Duty, Deceptive Trade Practices, and Legal Malpractice. Share issuances During the period October 1, 2018 through the date of this report, the Company issued 2,041,667 for services, which were issuable at September 30, 2018. During the period October 1, 2018 through the date of this report, the Company issued 1,118,333 in issuable shares sold in the quarter ended September 30, 2018. During the period October 1, 2018 through the date of this report, the Company issued 4,182,399 shares in connection with the settlement of the recorded derivative liability, which was $129,030 as of September 30, 2018. During the period October 1, 2018 through the date of this report, the Company issued 51,576 shares for the payment of interest. |
Basis of Presentation (Policies
Basis of Presentation (Policies) | 3 Months Ended |
Sep. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Operations | Nature of Operations Quantum Materials Corp., a Nevada corporation, and its wholly owned subsidiary, Solterra Renewable Technologies, Inc. (collectively referred to as the “Company”) are headquartered in San Marcos, Texas. The Company is a nanotechnology company specializing in the design, development, production and supply of quantum dots, including tetrapod quantum dots, a high-performance variant of quantum dots, and highly uniform nanoparticles, using its patented automated continuous flow production process. Quantum dots and other nanoparticles are expected to be increasingly utilized in a range of applications in the life sciences, television and display, solid state lighting, solar energy, battery, security ink, and sensor sectors of the market. Key uncertainties and risks to the Company include, but are not limited to, if and how quickly various industries adopt and fully embrace quantum dot technology and technological changes, including those developed by the Company’s competitors, rendering the Company’s technology uncompetitive or obsolete. |
Going Concern | Going Concern The Company recorded losses from continuing operations in the current period presented and has a history of losses. As of June 30, 2018, the Company had a working capital deficit of $5,385,949 and net cash used in operating activities was $(184,090) for the three months ended September 30, 2018. The ability of the Company to continue as a going concern is dependent upon its ability to reverse negative operating trends, obtain revenues from operations, raise additional capital, and/or obtain debt financing. In conjunction with anticipated revenue streams, management is currently negotiating equity and debt financing, the proceeds from which would be used to settle outstanding debts, to finance operations, and for general corporate purposes. However, there can be no assurance that the Company will be able to raise capital, obtain debt financing, or improve operating results sufficiently to continue as a going concern. The accompanying unaudited consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern. |
Basis of Presentation | Basis of Presentation: |
Use of Estimates | Use of Estimates: |
Financial Instruments | Financial Instruments: |
Property and Equipment | Property and Equipment: Furniture and fixtures 7 years Computers and software 3 years Machinery and equipment 3 - 10 years |
Licenses and Patents | Licenses and Patents: |
Debt Issuance Costs | Debt Issuance Costs: |
Earnings Per Share | Earnings per Share: “Earnings Per Share” |
Beneficial Conversion | Beneficial Conversion: |
Derivative Instruments | Derivative Instruments: Accounting for Derivative Instruments and Hedging Activities”, The Company estimates fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered consistent with the objective measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as freestanding warrants, the Company generally uses the Black-Scholes model, adjusted for the effect of dilution, because it embodies all the requisite assumptions (including trading volatility, estimated terms, dilution and risk-free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques (such as Black-Scholes model) are highly volatile and sensitive to changes in the trading market price of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, income (expense) going forward will reflect the volatility in these estimates and assumption changes. Increases in the trading price of the Company’s common stock and increases in fair value during a given financial quarter result in the application of non-cash derivative expense. Conversely, decreases in the trading price of the Company’s common stock and decreases in trading fair value during a given financial quarter result in the application of non-cash derivative income. |
Fair Value Measurements | Fair value measurements: |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In July 2017, the FASB issued ASU 2017-11—Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. ASU 2017-11 eliminates the requirement that a down round feature precludes equity classification when assessing whether an instrument is indexed to an entity’s own stock. A freestanding equity-linked financial instrument no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The Company elected to adopt ASU 2017-11 early, effective July 1, 2017, and implemented the pronouncement retrospectively with a cumulative effect adjustment to outstanding financial instruments. The adoption of this guidance did not have an impact on its financial statements. In the fiscal year 2018, the Company had three triggering events related to a down round feature which resulted in recording a charge for beneficial conversion expense of $1,021,500 during the year ended June 30, 2018. In March 2016, the FASB issued ASU guidance related to stock-based compensation. The new guidance simplifies the accounting for stock-based compensation transactions, including income tax consequences, statement of cash flows presentation, estimating forfeitures when calculating compensation expense, and classification of awards as either equity or liabilities. The new standard requires all excess tax benefits and tax deficiencies to be recognized as income tax benefit (expense) in the income statement. The new guidance also requires presentation of excess tax benefits as an operating activity on the statement of cash flows rather than a financing activity and requires presentation of cash paid to a tax authority when shares are withheld to satisfy the employer’s statutory income tax withholding obligation as a financing activity. The new guidance also provides for an election to account for forfeitures of stock-based compensation. The Company adopted the guidance effective July 1, 2017. With respect to the forfeiture election, the Company will continue its current practice of estimating forfeitures when calculating compensation expense. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements or related disclosures. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting. In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. The amendment provides guidance on accounting for the impact of the Tax Cuts and Jobs Act (the “Tax Act”) and allows entities to complete the accounting under ASC 740 within a one-year measurement period from the Tax Act enactment date. This standard is effective upon issuance. The Tax Act has several significant changes that impact all taxpayers, including a transition tax, which is a one-time tax charge on accumulated, undistributed foreign earnings. The Company adopted the guidance effective July 1, 2018. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements or related disclosures. In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718) – Scope of Modification Accounting. |
Pronouncements Yet to be Adopted | Pronouncements Yet To Be Adopted In February 2016, the FASB issued ASU 2016-02, Leases, In August 2014, the FASB issued ASU No. 2014-15 Preparation of Financial Statements — Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers Revenue from Contracts with Customers: Deferral of the Effective Date, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing. |
Basis of Presentation (Tables)
Basis of Presentation (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Property and Equipment Estimated Useful Lives | Depreciation is computed on the straight-line basis over the estimated useful lives of the various classes of assets as follows: Furniture and fixtures 7 years Computers and software 3 years Machinery and equipment 3 - 10 years |
Property and Equipment (Tables)
Property and Equipment (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | Property and equipment consisted of the following: September 30, 2018 June 30, 2018 (unaudited) Furniture and fixtures $ 3,502 $ 3,502 Computers and software 11,447 11,447 Machinery and equipment 956,655 956,655 971,604 971,604 Less: accumulated depreciation 371,086 346,080 Total property and equipment, net $ 600,518 $ 625,524 |
Licenses and Patents (Tables)
Licenses and Patents (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Finite-Lived Intangible Assets, Net [Abstract] | |
Schedule of Licenses and Patents | Licenses and patents consisted of the following: September 30, 2018 June 30, 2018 (unaudited) William Marsh Rice University $ 40,000 $ 40,000 University of Arizona 15,000 15,000 Bayer acquired patents 137,743 137,743 192,743 192,743 Less: accumulated amortization 153,716 146,852 Total licenses and patents, net $ 39,027 $ 45,891 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Fair Value Derivative Liability | The Company hired an independent resource to value its derivative liability as follows (unaudited): Fair Value Table Balance at September 30, 2018 Quoted Prices in Active Markets for Identical Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Derivative Liability $ 129,030 $ - $ - $ 129,030 Note Payable $ 20,000 - 20,000 - Convertible debentures 3,557,453 - 3,557,453 - $ 3,706,483 $ - $ 3,577,453 $ 129,030 |
Schedule of Derivative Liability Level Three Roll-forward | Level Three Roll-forward Derivative Liability Total Balance June 30, 2018 $ - $ - Fair value of derivative liability reclassified from equity 98,645 98,645 Settlement of derivative liabilities (51,777 ) (51,777 ) Change in fair value 82,162 82,162 Balance September 30, 2018 $ 129,030 $ 129,030 |
Schedule of Fair Value of Convertible Debentures | The following table sets forth the fair value of the Company’s convertible debentures as of September 30, 2018, and June 30, 2018: September 30, 2018 June 30, 2018 (unaudited) Carrying Fair Carrying Fair Amount Value Amount Value Convertible debentures issued in September 2014 $ 25,050 $ 29,044 $ 25,050 $ 27,977 Convertible debentures issued in January 2015 500,000 523,567 500,000 504,342 Convertible debentures issued in April - June 2016 1,075,000 1,198,851 1,075,000 1,154,831 Convertible debenture issued in August 2016 200,000 235,613 200,000 226,961 Convertible debentures issued in January - March 2017 60,000 66,583 60,000 64,138 Convertible promissory notes issued in March 2017 222,350 268,550 222,350 258,689 Convertible debenture issued in June 2017 100,000 102,689 100,000 98,919 Convertible debenture issued in July 2017 100,000 102,689 100,000 98,919 Convertible debenture issued in September 2017 150,000 154,034 150,000 148,378 Convertible debenture issued in September 2017 495,000 509,554 495,000 490,844 Convertible debenture issued in November 2017 27,000 26,521 27,000 25,547 Convertible debenture issued in November 2017 247,500 254,777 247,500 245,422 Convertible debenture issued in December 2017 75,000 75,252 75,000 72,489 Convertible debenture issued in February 2018 45,000 46,079 45,000 44,387 Convertible debentures issued in March 2018 65,000 65,614 65,000 63,205 Convertible debentures issued in April 2018 150,000 136,456 150,000 131,446 Convertible debentures issued in June 2018 40,000 41,614 40,000 40,086 Convertible debentures issued in July 2018 45,000 46,229 - - Convertible debentures issued in August 2018 30,000 30,101 - - Convertible debentures issued in September 2018 25,000 24,770 - - Convertible promissory note issued in September 2018 20,000 19,865 - - |
Convertible Debentures (Tables)
Convertible Debentures (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Schedule of Convertible Debentures | The following table sets forth activity associated with the convertible debentures: September 30, June 30, Debenture 2018 2018 Reference (unaudited) Convertible debentures issued in September 2014 $ 25,050 $ 25,050 A Convertible debentures issued in January 2015 500,000 500,000 B Convertible debentures issued in April - June 2016 1,075,000 1,075,000 C Convertible debenture issued in August 2016 200,000 200,000 C Convertible debentures issued in January - March 2017 60,000 60,000 D Convertible promissory notes issued in March 2017 222,350 222,350 G Convertible debenture issued in June 2017 100,000 100,000 I Convertible debenture issued in July 2017 100,000 100,000 J Convertible debenture issued in September 2017 645,000 645,000 K Convertible debenture issued in November 2017 247,500 247,500 K Convertible debenture issued in November 2017 27,000 27,000 L Convertible debenture issued in December 2017 75,000 75,000 N Convertible debenture issued in February 2018 45,000 45,000 O Convertible debentures issued in March 2018 65,000 65,000 P Convertible debentures issued in April 2018 60,000 60,000 Q Convertible debentures issued in April 2018 70,000 70,000 R Convertible debentures issued in April 2018 20,000 20,000 S Convertible debentures issued in June 2018 40,000 40,000 T Convertible debentures issued in July 2018 45,000 - U Convertible debentures issued in August 2018 30,000 - V Convertible debentures issued in September 2018 25,000 - W 3,676,900 3,576,900 Less: unamortized discount 119,447 134,255 3,557,453 3,442,645 Less: current portion 3,472,214 3,402,421 Total convertible debentures, net of current portion $ 85,239 $ 40,224 |
Equity Transactions (Tables)
Equity Transactions (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Equity [Abstract] | |
Summary of Activity of Company's Stock Warrants | A summary of activity of the Company’s stock warrants for the three months ended September 30, 2018 is presented below (unaudited): Weighted Weighted Average Weighted Average Remaining Average Exercise Number of Contractual Grant Date Price Warrants Term in Years Fair Value Balance as of June 30, 2018 $ 0.11 36,781,726 2.80 $ 0.09 Expired - - - Granted 0.10 3,702,250 0.04 Exercised - - - Cancelled - - - - Balance as of September 30, 2018 $ 0.11 40,483,976 2.49 $ 0.09 Vested and exercisable as of September 30, 2018 $ 0.11 40,483,976 2.49 $ 0.09 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Schedule of Valuation Assumptions Used to Estimate Fair Value of Stock Options | The following assumptions were used for the periods indicated: Three Months Ended September 30, 2018 2017 (unaudited) Expected volatility - 136.25 % Expected dividend yield - - Risk-free interest rates - 1.62 % Expected term (in years) - 5.0 |
Summary of Award Activity Under Stock Option Plans | A summary of the activity of the Company’s stock options for the three months ended September 30, 2018 is presented below (unaudited): Weighted Weighted Weighted Average Average Average Number of Remaining Optioned Aggregate Exercise Optioned Contractual Grant Date Intrinsic Price Shares Term in Years Fair Value Value Balance as of June 30, 2018 $ 0.09 85,616,914 4.00 $ 0.11 $ - Expired - - - Granted - - - Exercised - - - Cancelled - - - Balance as of September 30, 2018 $ 0.09 85,616,914 3.75 $ 0.11 $ - Vested and exercisable as of September 30, 2018 $ 0.08 78,634,747 3.77 $ 0.11 $ - |
Summary of Award Activity Under Restricted Stock Plans | A summary of the activity of the Company’s restricted stock awards for the three months ended September 30, 2018, and year ended June 30, 2018 is presented below (unaudited): Number of Nonvested, Unissued Restricted Share Awards Weighted Average Grant Date Fair Value Nonvested, unissued restricted shares outstanding at June 30, 2017 1,500,000 0.21 Granted 5,500,000 0.06 Vested (7,000,000 ) 0.09 Forfeited - - Nonvested, unissued restricted shares outstanding at June 30, 2018 - $ - Granted - - Vested - - Forfeited - - Nonvested, unissued restricted shares outstanding at September 30, 2018 - $ - |
Loss Per Share (Tables)
Loss Per Share (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Earnings Per Share [Abstract] | |
Schedule of Computation of Basic and Diluted Loss Per Share | The following table sets forth the computation of basic and diluted loss per share: Three Months Ended September 30, 2018 2017 (unaudited) Net loss $ (1,624,946 ) $ (3,027,097 ) Weighted average common shares outstanding: Basic and diluted 471,961,937 375,593,837 Basic and diluted loss per share $ (0.00 ) $ (0.01 ) |
Supplemental Cash Flow Inform_2
Supplemental Cash Flow Information (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Supplemental Cash Flow Elements [Abstract] | |
Schedule of Supplemental Cash Flow Information | The following is supplemental cash flow information: Three Months Ended September 30, 2018 2017 (unaudited) Cash paid for interest $ - $ 13,544 Cash paid for income taxes $ - $ - The following is supplemental disclosure of non-cash investing and financing activities: Three Months Ended September 30, 2018 2017 (unaudited) Conversion of debentures, and accrued interest into shares of common stock $ 21,342 $ 318,608 Allocated value of common stock and warrants issued with convertible debentures $ 75,202 $ 454,933 Stock issued for amount in accounts payable $ 61,255 $ - Prepaid expense paid in shares of common stock $ 164,588 $ 184,307 Financing of prepaid insurance $ - $ 10,056 |
Organization and Basis of Prese
Organization and Basis of Presentation (Details Narrative) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2017 | Jun. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Working capital deficit | $ 5,385,949 | |||
Net cash used in operating activities | $ (184,090) | $ (345,128) | $ (345,128) | |
Asset impairment charges | ||||
Accumulated amortization | 86,555 | $ 145,545 | ||
Amortization expense | $ 58,990 | $ 88,956 |
Organization and Basis of Pre_2
Organization and Basis of Presentation - Schedule of Property and Equipment Estimated Useful Lives (Details) | 12 Months Ended |
Jun. 30, 2018 | |
Furniture and Fixtures [Member] | |
Property and equipment estimated useful lives | 7 years |
Computer and Software [Member] | |
Property and equipment estimated useful lives | 3 years |
Machinery and Equipment [Member] | Minimum [Member] | |
Property and equipment estimated useful lives | 3 years |
Machinery and Equipment [Member] | Maximum [Member] | |
Property and equipment estimated useful lives | 10 years |
Property and Equipment (Details
Property and Equipment (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Property, Plant and Equipment [Abstract] | ||
Depreciation expense | $ 25,006 | $ 24,850 |
Property and Equipment - Schedu
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Property and equipment, gross | $ 971,604 | $ 971,604 |
Less: accumulated depreciation | 371,086 | 346,080 |
Total property and equipment, net | 600,518 | 625,524 |
Furniture and Fixtures [Member] | ||
Property and equipment, gross | 3,502 | 3,502 |
Computers and Software [Member] | ||
Property and equipment, gross | 11,447 | 11,447 |
Machinery and Equipment [Member] | ||
Property and equipment, gross | $ 956,655 | $ 956,655 |
Licenses and Patents (Details N
Licenses and Patents (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Finite-Lived Intangible Assets, Net [Abstract] | ||
Amortization expense | $ 6,864 | $ 9,637 |
Licenses and Patents - Schedule
Licenses and Patents - Schedule of Licenses and Patents (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Licenses and patents, gross | $ 192,743 | $ 192,743 |
Less: accumulated amortization | 153,716 | 146,852 |
Total licenses and patents, net | 39,027 | 45,891 |
William Marsh Rice University [Member] | ||
Licenses and patents, gross | 40,000 | 40,000 |
University of Arizona [Member] | ||
Licenses and patents, gross | 15,000 | 15,000 |
Bayer Acquired Patents [Member] | ||
Licenses and patents, gross | $ 137,743 | $ 137,743 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Schedule of Fair Value Derivative Liability (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Derivative Liability | $ 129,030 | |
Note Payable | 20,000 | |
Convertible debentures | 3,557,453 | |
Fair value of derivative liability | $ 3,706,483 | |
Level 1 [Member] | ||
Derivative Liability | ||
Note Payable | ||
Convertible debentures | ||
Fair value of derivative liability | ||
Level 2 [Member] | ||
Derivative Liability | ||
Note Payable | 20,000 | |
Convertible debentures | 3,557,453 | |
Fair value of derivative liability | 3,577,453 | |
Level 3 [Member] | ||
Derivative Liability | 129,030 | |
Note Payable | ||
Convertible debentures | ||
Fair value of derivative liability | $ 129,030 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Schedule of Derivative Liability Level Three Roll-forward (Details) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Beginning Balance | ||
Fair value of derivative liability reclassified from equity | 98,645 | |
Settlement of derivative liabilities | (51,777) | |
Change in fair value | 82,162 | $ (90,709) |
Ending Balance | 129,030 | |
Derivative Liability [Member] | ||
Beginning Balance | ||
Fair value of derivative liability reclassified from equity | 98,645 | |
Settlement of derivative liabilities | (51,777) | |
Change in fair value | 82,162 | |
Ending Balance | $ 129,030 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Schedule of Fair Value of Convertible Debentures (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Convertible debentures | $ 3,557,453 | |
Level 2 [Member] | ||
Convertible debentures | $ 3,557,453 | |
Convertible Debentures Issued in September 2014 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 25,050 | 25,050 |
Convertible Debentures Issued in September 2014 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 29,044 | 27,977 |
Convertible Debentures Issued in January 2015 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 500,000 | 500,000 |
Convertible Debentures Issued in January 2015 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 523,567 | 504,342 |
Convertible Debentures Issued in April - June 2016 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 1,075,000 | 1,075,000 |
Convertible Debentures Issued in April - June 2016 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 1,198,851 | 1,154,831 |
Convertible Debenture Issued in August 2016 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 200,000 | 200,000 |
Convertible Debenture Issued in August 2016 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 235,613 | 226,961 |
Convertible Debenture Issued in January - March 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 60,000 | 60,000 |
Convertible Debenture Issued in January - March 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 66,583 | 64,138 |
Convertible Promissory Notes Issued in March 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 222,350 | 222,350 |
Convertible Promissory Notes Issued in March 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 268,550 | 258,689 |
Convertible Debenture Issued in June 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 100,000 | 100,000 |
Convertible Debenture Issued in June 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 102,689 | 98,919 |
Convertible Debenture Issued in July 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 100,000 | 100,000 |
Convertible Debenture Issued in July 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 102,689 | 98,919 |
Convertible Debentures Notes Issued in September 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 150,000 | 150,000 |
Convertible Promissory Notes Issued in September 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 154,034 | 148,378 |
Convertible Promissory Notes Issued in September 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 495,000 | 495,000 |
Convertible Promissory Notes Issued in September 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 509,554 | 490,844 |
Convertible Debenture Issued in November 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 27,000 | 27,000 |
Convertible Debenture Issued in November 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 26,521 | 25,547 |
Convertible Debenture Issued in November 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 247,500 | 247,500 |
Convertible debenture issued in November 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 254,777 | 245,422 |
Convertible Debenture issued in December 2017 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 75,000 | 75,000 |
Convertible Debenture issued in December 2017 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 75,252 | 72,489 |
Convertible Debenture issued in February 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 45,000 | 45,000 |
Convertible Debenture issued in February 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 46,079 | 44,387 |
Convertible Debenture Issued in March 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 65,000 | 65,000 |
Convertible Debenture Issued in March 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 65,614 | 63,205 |
Convertible Debenture Issued in April 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 150,000 | 150,000 |
Convertible Debenture Issued in April 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 136,456 | 131,446 |
Convertible Debenture Issued in June 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 40,000 | 40,000 |
Convertible Debenture Issued in June 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 41,614 | 40,086 |
Convertible Debenture Issued in July 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 45,000 | |
Convertible Debenture Issued in July 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 46,229 | |
Convertible Debenture Issued in August 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 30,000 | |
Convertible Debentures Issued in August 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 30,101 | |
Convertible Debentures Issued in September 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 25,000 | |
Convertible Debentures Issued in September 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | 24,770 | |
Convertible Promissory Note Issued in September 2018 [Member] | Level 2 [Member] | Carrying Value [Member] | ||
Convertible debentures | 20,000 | |
Convertible Promissory Note Issued in September 2018 [Member] | Level 2 [Member] | Fair Value [Member] | ||
Convertible debentures | $ 19,865 |
Convertible Debentures (Details
Convertible Debentures (Details Narrative) - USD ($) | Jan. 24, 2018 | Oct. 31, 2016 | Oct. 10, 2016 | Jan. 15, 2015 | Sep. 30, 2018 | Aug. 31, 2018 | Jul. 31, 2018 | Jun. 30, 2018 | May 31, 2018 | Apr. 30, 2018 | Mar. 31, 2018 | Feb. 28, 2018 | Dec. 31, 2017 | Nov. 30, 2017 | Sep. 30, 2017 | Jul. 31, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Aug. 31, 2016 | Oct. 28, 2014 | Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | Sep. 16, 2014 |
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 3,676,900 | $ 3,576,900 | $ 3,676,900 | $ 3,576,900 | $ 3,576,900 | ||||||||||||||||||||||
Value of debenture converted into shares | 21,342 | $ 318,608 | |||||||||||||||||||||||||
Convertible promissory note | $ 3,557,453 | $ 3,442,645 | 3,557,453 | $ 3,442,645 | $ 3,442,645 | ||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 100,000 | 700,000 | |||||||||||||||||||||||||
Warrants exercise price per share | $ 0.04 | $ 0.04 | |||||||||||||||||||||||||
Derivative liability | $ 51,777 | $ 51,777 | |||||||||||||||||||||||||
Number of share issued | 513,333 | ||||||||||||||||||||||||||
Accretion of debt discount | $ 90,010 | 331,162 | |||||||||||||||||||||||||
Common stock, par value | $ .001 | $ .001 | $ .001 | $ .001 | $ .001 | ||||||||||||||||||||||
Beneficial conversion expense | $ 16,870 | 752,426 | |||||||||||||||||||||||||
Unamortization of debt discount | $ 119,447 | $ 134,255 | 119,447 | $ 134,255 | $ 134,255 | ||||||||||||||||||||||
Proceeds from issuance of common stock | 83,900 | 40,000 | |||||||||||||||||||||||||
September 2014 Convertible Debenture [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 500,050 | $ 500,050 | |||||||||||||||||||||||||
Debt term | 5 years | ||||||||||||||||||||||||||
Maturity date description | September 16, 2019 and October 30, 2019 | ||||||||||||||||||||||||||
Debt interest rate | 6.00% | 6.00% | |||||||||||||||||||||||||
Debenture, conversion price | $ 0.15 | $ 0.15 | |||||||||||||||||||||||||
Warrants strike price per share | $ 0.30 | ||||||||||||||||||||||||||
Warrants term | 5 years | ||||||||||||||||||||||||||
Value of debenture converted into shares | |||||||||||||||||||||||||||
Interest expense | 384 | 384 | |||||||||||||||||||||||||
Convertible promissory note | 25,050 | 25,050 | 25,050 | 25,050 | 25,050 | ||||||||||||||||||||||
January 2015 Convertible Debenture [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt term | 2 years | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.06 | ||||||||||||||||||||||||||
Interest expense | 10,082 | 10,082 | |||||||||||||||||||||||||
Convertible promissory note | 500,000 | 500,000 | 500,000 | ||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 500,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Jan. 15, 2018 | Dec. 15, 2017 | |||||||||||||||||||||||||
Common stock warrants exercisable | $ 6,250,000 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.06 | $ 0.06 | |||||||||||||||||||||||||
Warrants converted into common stock | 6,250,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 375,000 | ||||||||||||||||||||||||||
Number of share issued | 3,500,000 | ||||||||||||||||||||||||||
Debt extension expenses | $ 210,000 | ||||||||||||||||||||||||||
Allocated value of warrants related to debenture | $ 348,105 | ||||||||||||||||||||||||||
April - June, August, October and November 2016 Convertible Debentures [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 250,000 | $ 250,000 | $ 250,000 | ||||||||||||||||||||||||
Debt term | 2 years | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||
Debenture, conversion price | $ 0.012 | $ 0.12 | $ 0.012 | $ 0.12 | $ 0.012 | $ 0.12 | |||||||||||||||||||||
Warrants term | 5 years | 5 years | 5 years | ||||||||||||||||||||||||
Value of debenture converted into shares | $ 455,000 | $ 285,000 | |||||||||||||||||||||||||
Interest expense | 26,067 | $ 31,444 | |||||||||||||||||||||||||
Convertible promissory note | 1,275,000 | $ 1,275,000 | 1,275,000 | $ 1,275,000 | 1,275,000 | ||||||||||||||||||||||
Warrants exercise price per share | $ 0.15 | $ 0.15 | $ 0.15 | ||||||||||||||||||||||||
Warrants converted into common stock | 4,166 | ||||||||||||||||||||||||||
Allocated value of warrants related to debenture | 609,595 | ||||||||||||||||||||||||||
Accretion of debt discount | 2,564 | $ 96,331 | |||||||||||||||||||||||||
Sale of stock transaction during period, shares | 200 | 1,565 | |||||||||||||||||||||||||
Sale of stock transaction during period | $ 50,000 | $ 200,000 | $ 1,565,000 | ||||||||||||||||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
Beneficial conversion expense | $ 0 | $ 530,000 | |||||||||||||||||||||||||
Unregistered and restricted shares issued for conversion of debentures | 3,791,666 | 2,375,000 | |||||||||||||||||||||||||
April - June, August, October and November 2016 Convertible Debentures [Member] | March And April of 2019 [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 825,000 | 825,000 | $ 825,000 | ||||||||||||||||||||||||
April - June, August, October and November 2016 Convertible Debentures [Member] | Unsecured Convertible Promissory Note [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 1,000 | $ 1,000 | $ 1,000 | ||||||||||||||||||||||||
January-March 2017 Convertible Debentures [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | $ 0.12 | $ 0.12 | ||||||||||||||||||||||||
Warrants term | 5 years | 5 years | 5 years | ||||||||||||||||||||||||
Value of debenture converted into shares | 200,000 | ||||||||||||||||||||||||||
Interest expense | 1,210 | 8,529 | |||||||||||||||||||||||||
Convertible promissory note | 60,000 | 60,000 | $ 60,000 | 60,000 | 60,000 | ||||||||||||||||||||||
Warrants exercise price per share | $ 0.15 | $ 0.15 | $ 0.15 | ||||||||||||||||||||||||
Warrants converted into common stock | 4,166 | ||||||||||||||||||||||||||
Number of share issued | 1,666,667 | ||||||||||||||||||||||||||
Allocated value of warrants related to debenture | 73,250 | ||||||||||||||||||||||||||
Accretion of debt discount | $ 1,547 | 8,864 | |||||||||||||||||||||||||
Sale of stock transaction during period, shares | 2,600 | ||||||||||||||||||||||||||
Sale of stock transaction during period | $ 260,000 | ||||||||||||||||||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
March 2017 Convertible Promissory Notes [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 319,500 | 319,500 | 319,500 | ||||||||||||||||||||||||
Debt interest rate | 6.00% | ||||||||||||||||||||||||||
Interest expense | 0 | 8,364 | |||||||||||||||||||||||||
Convertible promissory note | 222,350 | $ 222,350 | 222,350 | 222,350 | |||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 285,000 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.13 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 86,673 | ||||||||||||||||||||||||||
Derivative liability | 307,301 | 307,301 | |||||||||||||||||||||||||
Accretion of debt discount | 0 | 43,661 | |||||||||||||||||||||||||
Unamortization of debt discount | 69,333 | 69,333 | |||||||||||||||||||||||||
Debt original issue discount | $ 31,850 | ||||||||||||||||||||||||||
Change in derivative liability benefit | 0 | 65,703 | |||||||||||||||||||||||||
Payment of convertible debt | 319,500 | ||||||||||||||||||||||||||
Recognized interest expense | 340,476 | ||||||||||||||||||||||||||
March 2017 Convertible Promissory Notes [Member] | Equity Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
March 2017 Convertible Promissory Notes [Member] | SBI Investment LLC [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Percentage of warrant to purchase shares | 50.00% | ||||||||||||||||||||||||||
March 2017 Convertible Promissory Notes [Member] | SBI Investment LLC [Member] | Equity Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Sale of stock transaction during period, shares | 5,000,000 | ||||||||||||||||||||||||||
Commitment fees | $ 63,000 | ||||||||||||||||||||||||||
March 2017 Convertible Promissory Notes [Member] | L2 Capital, LLC [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Percentage of warrant to purchase shares | 50.00% | ||||||||||||||||||||||||||
March 2017 Convertible Promissory Notes [Member] | L2 Capital, LLC [Member] | Equity Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Sale of stock transaction during period, shares | 5,000,000 | ||||||||||||||||||||||||||
Commitment fees | $ 147,000 | ||||||||||||||||||||||||||
June 2017 Convertible Debenture [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | ||||||||||||||||||||||
Derivative liability | 49,798 | 49,798 | 49,798 | ||||||||||||||||||||||||
June 2017 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of six months maturing on December 16, 2017 and stipulates a one-time interest charge of eight percent (8%) shall be applied on the issuance date to the principal. The maturity date of the Note was extended to May 1, 2018 in an extension agreement dated April 6, 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | $ 0.12 | $ 0.12 | ||||||||||||||||||||||||
Value of debenture converted into shares | $ 100,000 | ||||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Convertible promissory note | 100,000 | $ 100,000 | $ 100,000 | ||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 100,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Dec. 16, 2017 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | $ 0.12 | $ 0.12 | ||||||||||||||||||||||||
Warrants converted into common stock | 250,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 54,340 | ||||||||||||||||||||||||||
Accretion of debt discount | 0 | 27,079 | |||||||||||||||||||||||||
Beneficial conversion expense | 0 | 0 | |||||||||||||||||||||||||
July 2017 Convertible Debenture [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Interest expense | 0 | 8,000 | |||||||||||||||||||||||||
July 2017 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 100,000 | $ 100,000 | 100,000 | 100,000 | $ 100,000 | $ 100,000 | |||||||||||||||||||||
Maturity date description | The promissory note has a term of six months maturing on December 16, 2017 and stipulates a interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to May24, 2018 in an extension agreement dated April 6, 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 0 | 21,300 | |||||||||||||||||||||||||
Convertible promissory note | $ 100,000 | $ 100,000 | 100,000 | $ 100,000 | |||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 100,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Dec. 16, 2017 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 250,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 19,010 | ||||||||||||||||||||||||||
Accretion of debt discount | 0 | ||||||||||||||||||||||||||
Beneficial conversion expense | $ 45,544 | ||||||||||||||||||||||||||
Number common shares issuable | 1,000,000 | ||||||||||||||||||||||||||
Debt original issue discount | $ 53,876 | ||||||||||||||||||||||||||
Change in derivative liability benefit | 28,561 | ||||||||||||||||||||||||||
Proceeds from issuance of common stock | $ 100,000 | ||||||||||||||||||||||||||
September 2017 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 150,000 | 150,000 | $ 150,000 | 150,000 | 150,000 | $ 150,000 | 150,000 | ||||||||||||||||||||
Maturity date description | The promissory note has a term of six months maturing on March 26, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to February 1, 2019 in an extension agreement dated May 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | |||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | $ 0.12 | |||||||||||||||||||||||||
Interest expense | 0 | $ 12,000 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 150,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Mar. 26, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | $ 0.12 | |||||||||||||||||||||||||
Warrants converted into common stock | 375,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 19,240 | ||||||||||||||||||||||||||
Derivative liability | 22,666 | 22,666 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 45,219 | ||||||||||||||||||||||||||
Number common shares issuable | 1,650,000 | ||||||||||||||||||||||||||
Debt original issue discount | 0 | $ 8,587 | 0 | $ 8,587 | |||||||||||||||||||||||
Change in derivative liability benefit | 14,483 | ||||||||||||||||||||||||||
Proceeds from issuance of common stock | 165,000 | ||||||||||||||||||||||||||
September 2017 Convertible Debenture One [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 495,000 | 495,000 | $ 495,000 | 495,000 | 495,000 | $ 495,000 | 495,000 | ||||||||||||||||||||
Maturity date description | The promissory note has a term of seven months maturing on April 26, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to January 26, 2019 in an extension agreement dated April 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | |||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | $ 0.12 | |||||||||||||||||||||||||
Interest expense | 0 | $ 36,000 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 450,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Feb. 1, 2019 | Apr. 26, 2018 | |||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | $ 0.12 | |||||||||||||||||||||||||
Warrants converted into common stock | 2,000,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 318,337 | ||||||||||||||||||||||||||
Derivative liability | 43,998 | 43,998 | |||||||||||||||||||||||||
Debt extension expenses | 318,337 | ||||||||||||||||||||||||||
Accretion of debt discount | 0 | $ 7,429 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 131,663 | ||||||||||||||||||||||||||
Number common shares issuable | 10,000,000 | ||||||||||||||||||||||||||
Debt original issue discount | $ 45,000 | 45,000 | |||||||||||||||||||||||||
Change in derivative liability benefit | 28,864 | ||||||||||||||||||||||||||
Proceeds from issuance of common stock | 1,000,000 | ||||||||||||||||||||||||||
September 2017 Convertible Debenture Two [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 247,500 | 247,500 | $ 247,500 | 247,500 | 247,500 | 247,500 | |||||||||||||||||||||
Maturity date description | The promissory note has a term of six months maturing on April 26, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to January 26, 2019 in an extension agreement dated April 2018. | ||||||||||||||||||||||||||
Interest expense | 0 | 18,000 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 225,000 | ||||||||||||||||||||||||||
Debt original issue discount | 22,500 | ||||||||||||||||||||||||||
November 2017 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 27,000 | 27,000 | $ 27,000 | 27,000 | 27,000 | 27,000 | |||||||||||||||||||||
Debt term | 24 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of 24 months maturing on November 13, 2019 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 552 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 27,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Nov. 7, 2022 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.15 | ||||||||||||||||||||||||||
Warrants converted into common stock | 416,600 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 8,310 | ||||||||||||||||||||||||||
Accretion of debt discount | 780 | 0 | |||||||||||||||||||||||||
December 2017 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 75,000 | 75,000 | $ 75,000 | 75,000 | 75,000 | 75,000 | |||||||||||||||||||||
Debt term | 6 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of 6 months maturing on June 30, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to March 30, 2019 in an extension agreement dated June 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 75,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Jun. 30, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 250,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 41,175 | ||||||||||||||||||||||||||
Derivative liability | 10,380 | 10,380 | |||||||||||||||||||||||||
Accretion of debt discount | 0 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 16,176 | ||||||||||||||||||||||||||
Number common shares issuable | 1,000,000 | ||||||||||||||||||||||||||
Change in derivative liability benefit | 8,061 | ||||||||||||||||||||||||||
February 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 45,000 | ||||||||||||||||||||||||||
Debt term | 6 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of 6 months maturing on August 8, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to February 8, 2019 in an extension agreement dated August 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 45,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Aug. 8, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 500,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 31,546 | ||||||||||||||||||||||||||
Derivative liability | 64 | 64 | |||||||||||||||||||||||||
Accretion of debt discount | 6,761 | 0 | |||||||||||||||||||||||||
Number common shares issuable | 1,500,000 | ||||||||||||||||||||||||||
Change in derivative liability benefit | 64 | ||||||||||||||||||||||||||
March 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 30,000 | $ 30,000 | $ 30,000 | 30,000 | 30,000 | ||||||||||||||||||||||
Debt term | 6 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of 6 months maturing on August 8, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to March 6, 2019 in an extension agreement dated August 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Convertible promissory note | $ 30,000 | ||||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 30,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Aug. 8, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 500,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 23,374 | ||||||||||||||||||||||||||
Derivative liability | 2,073 | 2,073 | |||||||||||||||||||||||||
Accretion of debt discount | 8,677 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | 6,625 | ||||||||||||||||||||||||||
Number common shares issuable | 1,500,000 | ||||||||||||||||||||||||||
Change in derivative liability benefit | 2,078 | ||||||||||||||||||||||||||
March 2018 Convertible Debenture One [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 35,000 | ||||||||||||||||||||||||||
Debt term | 6 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of six months maturing on September 23, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to March 23, 2019 in an extension agreement dated September 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 35,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Sep. 23, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 500,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 26,298 | ||||||||||||||||||||||||||
Accretion of debt discount | 12,254 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 8,702 | ||||||||||||||||||||||||||
Number common shares issuable | 1,500,000 | ||||||||||||||||||||||||||
April 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 60,000 | 60,000 | $ 60,000 | 60,000 | 60,000 | 60,000 | |||||||||||||||||||||
Debt term | 6 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of approximately 6 months maturing on November 1, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. The maturity date of the Note was extended to May 1, 2019 in an extension agreement dated September 2018. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 60,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Nov. 1, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 1,000,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 41,175 | ||||||||||||||||||||||||||
Derivative liability | 48 | 48 | |||||||||||||||||||||||||
Accretion of debt discount | 20,673 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 6,175 | ||||||||||||||||||||||||||
Number common shares issuable | 2,000,000 | ||||||||||||||||||||||||||
Change in derivative liability benefit | 48 | ||||||||||||||||||||||||||
April 2018 Convertible Debenture One [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 70,000 | 70,000 | $ 70,000 | 70,000 | 70,000 | 70,000 | |||||||||||||||||||||
Debt term | 2 years | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of 2 years maturing on April 25, 2020 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 2,458 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 70,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Apr. 25, 2020 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 200,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 31,188 | ||||||||||||||||||||||||||
Accretion of debt discount | 3,685 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 0 | ||||||||||||||||||||||||||
Number common shares issuable | 1,000,000 | ||||||||||||||||||||||||||
April 2018 Convertible Debenture Two [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 20,000 | 20,000 | $ 20,000 | 20,000 | 20,000 | 20,000 | |||||||||||||||||||||
Debt term | 2 years | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of 2 years maturing on April 19, 2020 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 724 | 0 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 20,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Apr. 19, 2020 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.15 | ||||||||||||||||||||||||||
Warrants converted into common stock | 1,166,660 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 14,384 | ||||||||||||||||||||||||||
Accretion of debt discount | 1,709 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 4,384 | ||||||||||||||||||||||||||
June 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 40,000 | $ 40,000 | $ 40,000 | ||||||||||||||||||||||||
Debt term | 7 months | ||||||||||||||||||||||||||
Maturity date description | The promissory note has a term of approximately 7 months maturing on December 31, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | $ 0.12 | $ 0.12 | ||||||||||||||||||||||||
Interest expense | 0 | 0 | |||||||||||||||||||||||||
Convertible promissory note | $ 40,000 | $ 40,000 | $ 40,000 | ||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 40,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Dec. 31, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | $ 0.12 | $ 0.12 | ||||||||||||||||||||||||
Warrants converted into common stock | 1,000,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 31,957 | ||||||||||||||||||||||||||
Number of share issued | 2,000,000 | ||||||||||||||||||||||||||
Accretion of debt discount | 13,583 | 0 | |||||||||||||||||||||||||
Beneficial conversion expense | $ 8,044 | ||||||||||||||||||||||||||
June 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 40,000 | $ 40,000 | 40,000 | $ 40,000 | $ 40,000 | ||||||||||||||||||||||
Derivative liability | 0 | 0 | |||||||||||||||||||||||||
July 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 45,000 | $ 45,000 | 45,000 | ||||||||||||||||||||||||
Maturity date description | The promissory note has a term of approximately 7 months maturing on January 31, 2019 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 3,600 | ||||||||||||||||||||||||||
Convertible promissory note | $ 45,000 | ||||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 45,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Jan. 31, 2019 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 1,000,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 33,485 | ||||||||||||||||||||||||||
Derivative liability | 0 | 0 | |||||||||||||||||||||||||
Number of share issued | 2,000,000 | ||||||||||||||||||||||||||
Accretion of debt discount | 12,260 | ||||||||||||||||||||||||||
Beneficial conversion expense | $ 7,235 | ||||||||||||||||||||||||||
August 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | 30,000 | $ 30,000 | 30,000 | ||||||||||||||||||||||||
Maturity date description | The promissory note has a term of approximately 7 months maturing on March 30, 2019 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | ||||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | ||||||||||||||||||||||||||
Interest expense | 2,400 | ||||||||||||||||||||||||||
Convertible promissory note | $ 30,000 | ||||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 30,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Mar. 30, 2019 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | ||||||||||||||||||||||||||
Warrants converted into common stock | 1,000,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 22,659 | ||||||||||||||||||||||||||
Derivative liability | 0 | 0 | |||||||||||||||||||||||||
Number of share issued | 1,250,000 | ||||||||||||||||||||||||||
Accretion of debt discount | 4,450 | ||||||||||||||||||||||||||
Beneficial conversion expense | $ 5,160 | ||||||||||||||||||||||||||
September 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 25,000 | $ 25,000 | |||||||||||||||||||||||||
Maturity date description | The promissory note has a term of approximately 7 months maturing on April 30, 2018 and stipulates an interest charge of eight percent (8%) shall be applied to the principal. | ||||||||||||||||||||||||||
Debt interest rate | 8.00% | 8.00% | |||||||||||||||||||||||||
Debenture, conversion price | $ 0.12 | $ 0.12 | |||||||||||||||||||||||||
Interest expense | $ 2,000 | ||||||||||||||||||||||||||
Convertible promissory note | $ 25,000 | $ 25,000 | |||||||||||||||||||||||||
Proceeds from issuance of convertible debenture | $ 25,000 | ||||||||||||||||||||||||||
Debt instruments maturity date | Apr. 30, 2018 | ||||||||||||||||||||||||||
Warrants exercise price per share | $ 0.12 | $ 0.12 | |||||||||||||||||||||||||
Warrants converted into common stock | 1,000,000 | ||||||||||||||||||||||||||
Proceeds from issuance of warrants | $ 19,058 | ||||||||||||||||||||||||||
Derivative liability | $ 0 | $ 0 | |||||||||||||||||||||||||
Number of share issued | 2,000,000 | ||||||||||||||||||||||||||
Accretion of debt discount | 1,067 | ||||||||||||||||||||||||||
Beneficial conversion expense | $ 4,475 | ||||||||||||||||||||||||||
September 2018 Convertible Debenture [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Debt instrument principal amount | $ 25,000 | 25,000 | |||||||||||||||||||||||||
Debt [Member] | |||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||
Amortization expense | $ 90,010 | $ 24,376 |
Convertible Debentures - Schedu
Convertible Debentures - Schedule of Convertible Debentures (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Debt Instrument [Line Items] | ||
Convertible debenture | $ 3,676,900 | $ 3,576,900 |
Less: unamortized discount | 119,447 | 134,255 |
Total convertible debentures | 3,557,453 | 3,442,645 |
Less: current portion | 3,472,214 | 3,402,421 |
Total convertible debentures, net of current portion | 85,239 | 40,224 |
Convertible Debentures Issued in September 2014 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 25,050 | 25,050 |
Convertible Debentures Issued in January 2015 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 500,000 | 500,000 |
Convertible Debentures Issued in April - June 2016 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 1,075,000 | 1,075,000 |
Convertible Debenture Issued in August 2016 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 200,000 | 200,000 |
Convertible Debentures Issued in January - March, 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 60,000 | 60,000 |
Convertible Promissory Notes Issued in March 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 222,350 | 222,350 |
Convertible Debenture Issued in June 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 100,000 | 100,000 |
Convertible debenture issued in July 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 100,000 | 100,000 |
Convertible debenture issued in September 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 645,000 | 645,000 |
Convertible debenture issued in November 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 247,500 | 247,500 |
Convertible debenture issued in November 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 27,000 | 27,000 |
Convertible debenture issued in December 2017 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 75,000 | 75,000 |
Convertible debenture issued in February 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 45,000 | 45,000 |
Convertible debenture issued in March 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 65,000 | 65,000 |
Convertible debenture issued in April 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 60,000 | 60,000 |
Convertible debenture issued in April 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 70,000 | 70,000 |
Convertible debenture issued in April 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 20,000 | 20,000 |
Convertible debenture issued in June 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 40,000 | 40,000 |
Convertible debenture issued in July 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 45,000 | |
Convertible debenture issued in August 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | 30,000 | |
Convertible debenture issued in September 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Convertible debenture | $ 25,000 |
Notes Payable (Details Narrativ
Notes Payable (Details Narrative) | 1 Months Ended |
Sep. 30, 2018USD ($)$ / shares | |
Notes payable | $ 20,000 |
CEO [Member] | |
Secured promissory note | $ 20,000 |
Debt interest rate | 6.00% |
Debt maturity date | Mar. 9, 2019 |
Interest expense | $ 69 |
Lender [Member] | |
Debt, conversion price | $ / shares | $ .04 |
Equity Transactions (Details Na
Equity Transactions (Details Narrative) - USD ($) | Jun. 30, 2018 | Sep. 30, 2018 |
Number of common stock shares issued for services | 1,041,667 | |
Number of common stock shares issued for services, value | $ 43,333 | |
Common stock issued for debenture interest, shares | 344,055 | |
Common stock issued for debenture interest | $ 21,997 | |
Common stock issued for debenture conversions, shares | 4,516,553 | |
Common stock issued for debenture conversions | $ 180,663 | |
Debenture derivative liabilities | $ 51,777 | |
Number of common stock shares issued | 513,333 | |
Number of common stock value issued | $ 30,800 | |
Number of common stock issuable | 31,313,779 | |
Number of shares exchanged in extinguishment of debenture | 3,500,000 | |
Common stock exchanged in extinguishment of debenture amount | $ 150,000 | |
Number of common stock shares issued for settlement of a derivative liability | 991,279 | |
Number of common stock shares issued for settlement of a derivative liability, value | $ 39,651 | |
Deemed interest on extinguishment of debt | $ 36,000 | |
Number of shares issued in relation to extension of debt | 600,000 | |
Number of shares relation to new debenture borrowing, shares | 23,750,000 | |
Number of shares relation to new debenture borrowing, value | $ 835,000 | |
Number of common stock shares issued for cash, shares | 1,430,833 | |
Number of common stock shares issued for cash, value | $ 73,900 | |
Warrants to purchase common stock | 702,250 | |
Warrants exercise price per share | $ 0.04 | |
Number of common stock issued for reduction in shares issuable, shares | 513,333 | |
Number of common stock issued for reduction in shares issuable, value | $ 30,800 | |
Warrants outstanding | $ 4,538,009 | |
July 2018 to January 2023 [Member] | Minimum [Member] | ||
Warrants exercise price per share | $ 0.03 | |
July 2018 to January 2023 [Member] | Maximum [Member] | ||
Warrants exercise price per share | $ 0.30 | |
Common Stock [Member] | ||
Number of common stock value issued | $ 280,000 | |
Consulting Services [Member] | ||
Number of common stock shares issued for services | 3,031,375 | |
Number of common stock shares issued for services, value | $ 61,255 | $ 121,255 |
Equity Transactions - Summary o
Equity Transactions - Summary of Activity of Company's Stock Warrants (Details) - Warrant [Member] | 3 Months Ended |
Sep. 30, 2018$ / sharesshares | |
Weighted Average Exercise Price Beginning Balance | $ 0.11 |
Weighted Average Exercise Price Expired | |
Weighted Average Exercise Price Granted | 0.10 |
Weighted Average Exercise Price Exercised | |
Weighted Average Exercise Price Cancelled | |
Weighted Average Exercise Price Ending Balance | 0.11 |
Weighted Average Exercise Price Vested and exercisable | $ 0.11 |
Number of Warrants Beginning Balance | shares | 36,781,726 |
Number of Warrants Expired | shares | |
Number of Warrants Granted | shares | 3,702,250 |
Number of Warrants Exercised | shares | |
Number of Warrants Cancelled | shares | |
Number of Warrants Ending Balance | shares | 40,483,976 |
Number of Warrants Vested and exercisable | shares | 40,483,976 |
Weighted Average Remaining Contractual Term in Years | 2 years 9 months 18 days |
Weighted Average Remaining Contractual Term in Years | 2 years 5 months 27 days |
Weighted Average Remaining Contractual Term in Years Vested and exercisable | 2 years 5 months 27 days |
Weighted Average Grant Date Fair Value Beginning Balance | $ 0.09 |
Weighted Average Grant Date Fair Value Expired | |
Weighted Average Grant Date Fair Value Granted | 0.04 |
Weighted Average Grant Date Fair Value Exercised | |
Weighted Average Grant Date Fair Value Cancelled | |
Weighted Average Grant Date Fair Value Ending Balance | 0.09 |
Weighted Average Grant Date Fair Value Vested and exercisable | $ 0.09 |
Stock-Based Compensation (Detai
Stock-Based Compensation (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||
Jun. 30, 2017 | Mar. 31, 2017 | Jun. 30, 2016 | Mar. 31, 2012 | Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2017 | Jun. 30, 2018 | Feb. 17, 2016 | Mar. 31, 2013 | Jan. 31, 2013 | Dec. 31, 2010 | Oct. 31, 2009 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Stock option outstanding | 85,616,914 | 85,616,914 | |||||||||||
Expected (life) term | 5 years | ||||||||||||
Dividend yield | |||||||||||||
Stock Options [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Options granted, shares | 17,000,000 | 6,000,000 | 3,500,000 | 17,000,000 | |||||||||
Options term | 10 years | 10 years | 5 years | ||||||||||
Options cancelled, shares | 3,000,000 | 3,000,000 | 3,000,000 | ||||||||||
Stock option outstanding | 23,500,000 | 23,500,000 | 23,500,000 | ||||||||||
Dividend yield | 0.00% | ||||||||||||
Compensation expense | $ 207,452 | $ 207,451 | |||||||||||
Nonvested stock option awards, shares | 6,982,167 | ||||||||||||
Period of nonvested stock option awards not yet recognized for recognition | 1 year | ||||||||||||
Cost of nonvested stock option awards not yet recognized | $ 487,582 | ||||||||||||
Stock Options [Member] | Minimum [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Options term | 5 years | ||||||||||||
Historical forfeiture rates | 14.00% | ||||||||||||
Expected (life) term | 30 months | ||||||||||||
Option expiration year | 2019-02 | ||||||||||||
Stock option exercise price per share | $ 0.05 | ||||||||||||
Stock Options [Member] | Maximum [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Options term | 10 years | ||||||||||||
Historical forfeiture rates | 17.00% | ||||||||||||
Expected (life) term | 60 months | ||||||||||||
Option expiration year | 2026-06 | ||||||||||||
Stock option exercise price per share | $ 0.17 | ||||||||||||
Stock Options [Member] | Stock Option Plan Authorized 2009 [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Number of common stock authorized, shares | 10,000,000 | 7,500,000 | |||||||||||
Options granted, shares | 9,200,000 | ||||||||||||
Options cancelled, shares | 800,000 | ||||||||||||
Stock option outstanding | 8,400,000 | ||||||||||||
Number of restricted stock shares issued | 1,500,000 | ||||||||||||
Number of shares available for grant under the plan | 100,000 | ||||||||||||
Stock Options [Member] | Stock Option Plan Authorized 2009 [Member] | Minimum [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Options term | 5 years | ||||||||||||
Stock Options [Member] | Stock Option Plan Authorized 2009 [Member] | Maximum [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Options term | 10 years | ||||||||||||
Stock Options [Member] | Stock Option Plan Authorized 2013 [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Number of common stock authorized, shares | 60,000,000 | 20,000,000 | |||||||||||
Options granted, shares | 72,653,473 | ||||||||||||
Options cancelled, shares | 18,886,559 | ||||||||||||
Stock option outstanding | 50,441,914 | ||||||||||||
Options exercised, shares | 3,325,000 | ||||||||||||
Stock Options [Member] | 2015 Employee Benefit And Consulting Services Compensation Plan [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Number of common stock authorized, shares | 15,000,000 | ||||||||||||
Options granted, shares | 4,900,000 | ||||||||||||
Options term | 5 years | ||||||||||||
Options cancelled, shares | 1,625,000 | ||||||||||||
Stock option outstanding | 3,275,000 | ||||||||||||
Extended Term [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Options term | 5 years | ||||||||||||
Restricted Stock [Member] | |||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Compensation expense | $ 0 | $ 50,222 | |||||||||||
Option vesting period | 3 years | ||||||||||||
Cost of nonvested stock option awards not yet recognized | $ 0 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of Valuation Assumptions Used to Estimate Fair Value of Stock Options (Details) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||
Expected volatility | 136.25% | |
Expected dividend yield | ||
Risk-free interest rates | 1.62% | |
Expected term (in years) | 5 years |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Award Activity Under Stock Option Plans (Details) | 3 Months Ended |
Sep. 30, 2018USD ($)$ / sharesshares | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Weighted Average Exercise Price, Beginning Balance | $ 0.09 |
Weighted Average Exercise Price, Expired | |
Weighted Average Exercise Price, Granted | |
Weighted Average Exercise Price, Exercised | |
Weighted Average Exercise Price, Cancelled | |
Weighted Average Exercise Price, Ending Balance | 0.09 |
Weighted Average Exercise Price, Vested and exercisable | $ 0.08 |
Number of Optioned Shares, Beginning Balance | shares | 85,616,914 |
Number of Optioned Shares, Expired | shares | |
Number of Optioned Shares, Granted | shares | |
Number of Optioned Shares, Exercised | shares | |
Number of Optioned Shares, Cancelled | shares | |
Number of Optioned Shares, Ending Balance | shares | 85,616,914 |
Number of Optioned Shares, Vested and exercisable | shares | 78,634,747 |
Weighted Average Remaining Contractual Term in Years, Beginning Balance | 4 years |
Weighted Average Remaining Contractual Term in Years, Ending Balance | 3 years 9 months |
Weighted Average Remaining Contractual Term in Years, Vested and exercisable | 3 years 9 months 7 days |
Weighted Average Optioned Grant Date Fair Value, Beginning Balance | $ 0.11 |
Weighted Average Optioned Grant Date Fair Value, Expired | |
Weighted Average Optioned Grant Date Fair Value, Granted | |
Weighted Average Optioned Grant Date Fair Value, Exercised | |
Weighted Average Optioned Grant Date Fair Value, Cancelled | |
Weighted Average Optioned Grant Date Fair Value, Ending Balance | 0.11 |
Weighted Average Optioned Grant Date Fair Value, Vested and exercisable | $ 0.11 |
Aggregate Intrinsic Value, Beginning Balance | $ | |
Aggregate Intrinsic Value, Ending Balance | $ | |
Aggregate Intrinsic Value, Vested and exercisable | $ |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of Award Activity Under Restricted Stock Plans (Details) - Restricted Stock [Member] - $ / shares | 3 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Jun. 30, 2018 | |
Number of Unissued Restricted Shares Awards, Beginning Balance | 1,500,000 | |
Number of Unissued Restricted Shares Awards, Granted | 5,500,000 | |
Number of Unissued Restricted Shares Awards, Vested | (7,000,000) | |
Number of Unissued Restricted Shares Awards, Forfeited | ||
Number of Unissued Restricted Shares Awards, Ending Balance | ||
Weighted Average Grant Date Fair Value, Beginning Balance | $ 0.21 | |
Weighted Average Grant Date Fair Value, Granted | 0.06 | |
Weighted Average Grant Date Fair Value, Vested | 0.09 | |
Weighted Average Grant Date Fair Value, Forfeited | ||
Weighted Average Grant Date Fair Value, Ending Balance |
Loss Per Share - Schedule of Co
Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Earnings Per Share [Abstract] | ||
Net loss | $ (1,624,946) | $ (3,027,097) |
Weighted average common shares outstanding: Basic and diluted | 471,961,937 | 375,593,837 |
Basic and diluted loss per share | $ 0 | $ (0.01) |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
Rental expense | $ 18,864 | $ 29,952 |
Licensing Agreement [Member] | Solterra Renewable Technologies Inc [Member] | University of Arizona [Member] | ||
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
Royalties payable due in first installment period | 50,000 | |
Royalties payable due in second installment period | 125,000 | |
Royalties, future minimum payments due on each june 30 every year thereafter | $ 200,000 | |
License Agreements [Member] | Solterra Renewable Technologies Inc [Member] | Non-display Electronic Component Applications [Member] | University of Arizona [Member] | ||
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
Percentage of adjusted gross sales | 2.00% | |
License Agreements [Member] | Solterra Renewable Technologies Inc [Member] | Printed Electronic Displays [Member] | University of Arizona [Member] | ||
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
Percentage of adjusted gross sales | 2.50% |
Litigation (Details Narrative)
Litigation (Details Narrative) - USD ($) | Sep. 21, 2018 | Nov. 03, 2017 | Sep. 30, 2017 | Nov. 30, 2017 | Sep. 30, 2017 | Apr. 30, 2017 | Sep. 30, 2018 | Dec. 31, 2016 |
Litigation settlement | $ 129,000 | |||||||
Litigation interest arrears | $ 95,000 | |||||||
Number of common stock shares issued as collateral | 1,430,833 | |||||||
Quantum's CEO [Member] | ||||||||
Repayment to Related Party | $ 300,000 | |||||||
L2 Capital, LLC [Member] | ||||||||
Litigation interest arrears | $ 149,555 | $ 237,300 | ||||||
SBI Investments LLC [Member] | ||||||||
Litigation interest arrears | $ 64,095 | 101,700 | ||||||
SBI Investments LLC and L2 Capital, LLC [Member] | ||||||||
Repayment of loans | $ 213,650 | $ 339,000 | ||||||
Accrued interest | $ 10,170 | $ 8,636 | $ 10,170 | |||||
Damages sought, value per month | $ 100,000 | |||||||
Accrued damage sought value | $ 319,000 | |||||||
SBI Investments LLC and L2 Capital, LLC [Member] | Four LoanAgreement [Member] | ||||||||
Number of common stock shares issued as collateral | 50,000,000 | |||||||
SBI, L2 and Cleveland Terrazas PLLC [Member] | Lenders [Member] | ||||||||
Percentage of interest claimed | 140.00% | |||||||
Number of shares issued for damages claim | 20,000,000 | |||||||
SBI, L2 and Cleveland Terrazas PLLC [Member] | Four Notes [Member] | ||||||||
Repayment of default amount | $ 1,500,000 |
Supplemental Cash Flow Inform_3
Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Supplemental Cash Flow Elements [Abstract] | ||
Cash paid for interest | $ 13,544 | |
Cash paid for income taxes | ||
Conversion of debentures, and accrued interest into shares of common stock | 21,342 | 318,608 |
Allocated value of common stock and warrants issued with covertible debentures | 75,202 | 454,933 |
Stock issued for amounts in accounts payable | 61,255 | |
Prepaid expense paid in shares of common stock | 164,588 | 184,307 |
Financing of prepaid insurance | $ 10,056 |
Transactions with Affiliated _2
Transactions with Affiliated Parties (Details Narrative) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2017 | Sep. 30, 2016 | |
Related Party Transaction [Line Items] | ||||
Proceeds from issuance of convertible debenture | $ 100,000 | $ 700,000 | ||
Executives [Member] | ||||
Related Party Transaction [Line Items] | ||||
Due to related party | $ 593,075 | $ 284,275 | ||
Chief Financial Officer [Member] | ||||
Related Party Transaction [Line Items] | ||||
Due to related party | $ 100,000 | |||
Convertible Debt [Member] | Family Member of Former Key Executive [Member] | ||||
Related Party Transaction [Line Items] | ||||
Proceeds from issuance of convertible debenture | $ 200,000 |
Subsequent Events (Details Narr
Subsequent Events (Details Narrative) - USD ($) | Sep. 30, 2018 | Sep. 21, 2018 | Sep. 30, 2018 | Dec. 31, 2016 |
Number of common stock shares issued for services | 1,041,667 | |||
Number of common stock shares issued for settlement of a derivative liability | 991,279 | |||
Number of common stock shares issued for settlement of a derivative liability, value | $ 39,651 | |||
October 1, 2018 Through December 31, 2018 [Member] | ||||
Number of common stock shares issued for services | 2,041,667 | |||
Number of issuable shares sold | 1,118,333 | |||
Number of common stock shares issued for settlement of a derivative liability | 4,182,399 | |||
Number of common stock shares issued for settlement of a derivative liability, value | $ 129,030 | |||
Number of common stock shares issued for payment of interest | 51,576 | |||
Quantum's CEO [Member] | ||||
Repayment to Related Party | $ 300,000 | |||
SBI, L2 and Cleveland Terrazas PLLC [Member] | ||||
Damages sought, value per month | $ 100,000 | |||
Accrued legal expense | $ 319,000 |